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ABSTRACT !
This study investigated the effects of exogenous melatonin on people’s sleep, ability to perform 
an emotional Stroop task, and underlying brain architecture. 10 healthy adults (age = 26.8 ± 6.25 
years) underwent a baseline period followed by an experimental period whereby melatonin was 
administered at inappropriate times, with daily activity logs kept throughout. The emotional 
Stroop task was performed four times during each period, followed by an MRI scan. Following 
melatonin administration, sleep and wake times were significantly shifted and sleep quality 
ratings were significantly decreased compared to baseline values. Additionally, processing of 
emotional words but not faces was negatively affected by the melatonin treatment. Fractional 
anisotropy and mean diffusivity values were also significantly altered in the inferior frontal 
gyrus. It is inferred that the melatonin treatment induced circadian desynchronization, resulting 
in behavioural changes and structural alterations in brain regions involved in performance of the 
emotional Stroop task. 
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1. Introduction 
1.1 General Introduction 
 
1.1.1 A Brief Historical Review of Chronobiology 
 
 The daily changes in environmental light conditions resulting from the rotation of the 
earth have had profound impacts on all aspects of life. One such impact has been on the 
evolution of rhythmic physiological processes in living organisms. The world in which we live 
consists of a solar day with alternating periods of light and dark, and as such, organisms have 
adapted by synchronizing their own activities with these light/dark cycles. This synchronization 
of activities is important as it allows for the anticipation of change before the need arises – for 
example, blood glucose levels rising prior to one’s awakening – and as timing is required for 
anticipation, so too are clocks required for timing. Though much is now known about biological 
clocks and their sophisticated timing mechanisms, it is important to highlight the early 
experiments in plants and insects that aided in their discovery and the eventual discovery of the 
mammalian circadian system as a whole. 
 In 1729, Jean-Jacques d’Ortous de Mairan detailed the first encounter with internal 
biological clocks. de Mairan observed that the leaflets of the plant Mimosa pudica folded 
together and hung downwards during the night and unfolded and expanded during the day (de 
Mairan, 1729). He further noted that these behaviours did not change when Mimosa pudica was 
placed in continuous darkness – that is, the leaflets continued to fold and unfold rhythmically in 
synchrony with the external light/dark cycle, despite being unable to detect it directly (de 
Mairan, 1729). This simple yet remarkable experiment was the first demonstration of an 
internally generated 24 hour rhythmicity, contrary to previous presumption that they occurred as 
a direct response to environmental and external light cues. The work of de Mairan and others led 
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to the definition of three specific criteria that a rhythm must fulfill in order for it to be considered 
circadian in nature. First, circadian rhythms must persist in an aperiodic environment, as was 
exhibited by the behaviours of Mimosa pudica in the absence of light. Organisms placed in an 
aperiodic environment have rhythms that continue in the absence of environmental cues, free-
running with a period length of approximately 24 hours. Second, circadian rhythms must have 
free-running period lengths that are close to, but not exactly, 24 hours. That is, in constant 
aperiodic environments the rhythm must persist such that the interval between consecutive peaks 
or troughs, also known as the period, is roughly 24 hours. Internal clocks have natural period 
lengths that are either slightly shorter or slightly longer than 24 hours (with the range being 
approximately 19 to 26 hours in length), and these varying period lengths are constant and 
characteristic of a particular clock. Lastly, the rhythm must have a period length that is 
temperature compensated. As biological clocks are relatively insensitive to temperature changes, 
the free running period length of the clock must also not change greatly with fluctuating 
temperatures. 
 A second key contribution to the study of biological clocks, or chronobiology, came with 
the conceptualization of the transcription-translation feedback loop (TTFL) in Drosophila by 
Hardin, Hall, and Rosbash (Hardin et al., 1990; Figure 1). In brief, the mechanisms of this first-
described TTFL model were as follows: the CLOCK (CLK) and CYCLE (CYC) proteins within 
clock cells form a heterodimer and translocate into the nucleus, acting as a transcription activator 
by binding to the E-box element in the promoters of two of the most widely recognized clock 
genes, period (Per) and timeless (Tim). As a result of the stimulation of these genes, transcription 
of Per and Tim mRNA and the eventual translation of the mRNA into PER and TIM proteins 
occurs. The PER and TIM proteins then come together to form PER/TIM heterodimers, the 
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formation of which inhibits the CLK/CYC heterodimers from further activating transcription. 
This binding of TIM to PER not only acts as a negative feedback on the TTFL, but also serves to 
protect PER from phosphorylation. During the day, TIM is degraded by cryptochrome (CRY), a 
protein that is involved in blue light photoreception in insects. Thus, in the presence of blue light 
during daytime CRY is activated, TIM is degraded, and PER is continuously susceptible to 
phosphorylation by double-time (DBT), a non-cyclical casein kinase. During the night, however, 
levels of TIM increase as there is no longer blue light input to CRY and therefore no more 
degradation of TIM. Concomitantly, protein phosphatase 2A works to undo the actions of DBT 
by cyclically dephosphorylating PER until the levels of PER are high enough to dimerize with 
TIM.  
 As our knowledge of the circadian system further developed, several deficiencies in this 
TTFL model were noted. Firstly, prokaryotic blue-green bacteria have molecular oscillators and 
are capable of performing circadian timekeeping, though they do not possess a nucleus nor any 
of the aforementioned mechanisms (Lakin-Thomas, 2000). Additionally, the proposed model 
consists of mechanisms that are not temperature compensated (Lakin-Thomas, 2000). 
Furthermore, the biochemistry of this TTFL model would occur quite rapidly, as transcription, 
translation and nuclear transport takes mere minutes; thus there must be an additional component 
to the model that slows the mechanism down to a circadian period length (Lakin-Thomas, 2000). 
Lastly, it seems that PER and TIM must be multifunctional, as their levels within clock cells are 
much higher than what is needed solely for transcription activation and inhibition purposes 
(Lakin-Thomas, 2000). Although now recognized as being overly simplistic and largely 
inadequate for explaining the molecular basis of the clock, the importance of this initial TTFL 
model cannot be overlooked as it demonstrated the first workings of the machinery within clock 
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cells. 
 The Drosophila TTFL is now known to consist of multiple interlocking feedback loops 
and involve several dozen genes and their protein products (Hardin, 2011). Posttranslational 
modifications to the key clock proteins are now also known to regulate the period length of the 
clock to about 24 hours by introducing temporal delays into the mechanism. For example, 
phosphorylation has been shown to affect the timing of the clock through its actions on PER and 
TIM. Direct phosphorylation of PER by DBT in the cytoplasm destabilizes PER until levels of 
TIM in the cytoplasm accumulate to sufficient levels, which introduces a temporal delay between 
transcription of per and tim and the dimerization of PER/TIM (Harms et al., 2004). Additionally, 
3 kinases have been found in Drosophila that regulate the translocation of PER/TIM from the 
cytoplasm to the nucleus: DBT, SHAGGY (SGG), and Casein Kinase II (CKII). While DBT has 
been shown to play a role in the temporal gating of nuclear entry by phosphorylating PER (Bao 
et al., 2001), SGG and CKII have been shown to promote the nuclear accumulation of PER and 
TIM through the phosphorylation of TIM and PER, respectively (Martinek et al., 2001; Lin et 
al., 2002). As most features of the Drosophila clockwork are conserved in mammals, these 
advances have allowed for a better understanding of the mechanisms underlying not only the 
insect molecular clock, but the mammalian molecular clock as well. 
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Figure 1. Model of the Drosophila TTFL. CLK and CYC act as activators while PER and TIM act as 
repressors. Image obtained from Allada and Chung, 2010.   
 
 
1.1.2 Mechanisms of the Mammalian Molecular Clock 
 
 Much of our current knowledge in the field of chronobiology can be attributed to research 
on circadian rhythms in models varying from bacteria and plants to insects and birds. It was not 
until the relatively recent use of mammalian models that scientists were able to get a first 
glimpse of the workings behind the human circadian system. Though similar to that of lower 
animal models, the mammalian circadian system is much more complex and possesses a few 
significant differences that makes it unique and often times, difficult to study.  
 Mammals have an analogous core molecular mechanism to Drosophila that consists of 
two transcription factors: a mammalian homolog of CLOCK (CLK) and BMAL1. The 
CLK/BMAL1 heterodimers, similar to the CLK/CYC heterodimers in Drosophila, activate 
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transcription of the mammalian clock gene homologs of period (of which there are three genes; 
Per1, Per2, and Per3) and cryptochrome (of which there are two genes; Cry1 and Cry2) by 
binding to the E-box element in the promoters of these genes (King et al., 1997; Gekakis et al., 
1998). Per and Cry are subsequently transcribed and translated into their mRNA and protein 
counterparts, respectively, and the PER and CRY proteins then dimerize to form complexes that 
translocate into the nucleus. Inside the nucleus, these PER/CRY heterodimers work by inhibiting 
the CLK/BMAL1-induced transactivation of Per and Cry (Shearman et al., 2000; Lee et al., 
2001; Sato et al., 2006). Unlike the Drosophila TTFL model, however, levels of PER do not 
fluctuate because of the phosphorylation/dephosphorylation process; rather, regulation in the 
mammalian model comes from the secondary and independent functions of PER and CRY. Ye et 
al. (2011) found that CRY binds to the CLK/BMAL1/E-box complex independently of PER and 
destabilizes it, resulting in the inhibition of transcription. They further found that PER interferes 
with the binding of CRY to CLK/BMAL1/E-box, thus allowing for continuous transcription 
activation as CRY is no longer able to destabilize the complex (Ye et al., 2011). Today, this 
modern model has become widely accepted and has allowed for a more comprehensive 
understanding of the mammalian circadian clock (Figure 2). 
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Figure 2. Model of the mammalian circadian clock. CLOCK and BMAL1 proteins act as activators while 
PER and CRY proteins act as repressors. Image obtained from Partch et al., 2014.   
 
 
1.1.3 The Mammalian Circadian System 
 
 Endogenous circadian rhythms in mammals are generated and regulated by the “central 
clock” located in the suprachiasmatic nucleus (SCN) of the hypothalamus. The SCN was first 
discovered to play an important role in mammals by Robert Y. Moore in the early 1970s from 
studies using rats, mice, and hamsters. It was found that lesions of the SCN in these animals 
caused ablation of many important rhythms such as activity rhythms, sleeping rhythms, body 
temperature rhythms, and endocrine rhythms (Moore and Eichler, 1972; Moore and Lenn, 1972; 
Stephan and Zucker, 1972a and 1972b; Moore and Klein, 1974). The SCN was further found to 
control the period lengths of numerous free-running rhythms, though the clock cells within the 
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SCN are not directly photosensitive. It is now known that entrainment of these clock cells occurs 
through an alternate route – via neural pathways, primarily through the neural pathway from the 
eye. Two nerves connect the eyes to the brain: the optic nerve (ON), which acts as an indirect 
communication pathway connecting visual photoreception to the visual processing centers in the 
brain, and the retino-hypothalamic tract (RHT), which uses the neurotransmitter glutamate to 
provide direct nervous communication between the eyes and the SCN and is the primary route 
through which the SCN is entrained. The RHT is bidirectional, in that it not only provides 
afferent input from the eyes to the SCN, it also transmits efferent rhythmic output from the SCN 
back to the retina (Moore and Lenn, 1972; Johnson et al., 1988). Traditional clock genes are 
expressed in a variety of cell types in the mammalian retina, including photoreceptors and some 
retinal ganglion cells. These retinal ganglion cells are clock cells and are directly photosensitive 
as they contain an opsin-based pigment known as melanopsin (Hattar et al., 2002); these retinal 
ganglion cells have axons that travel down the RHT, directly innervating the SCN and providing 
light information to its component clock cells. Aside from the RHT, light information can also 
reach the SCN through the lateral hypothalamic tract (LHT), which innervates the SCN and 
relays information from the eyes by use of the neurotransmitter neuropeptide Y (NPY). 
 The circadian timing system in the head of mammals not only consists of the eyes and the 
SCN – a third structure known as the pineal gland aids in the overall organization of circadian 
rhythms. Though in birds the pineal gland is known to be an autonomous clock, the pineal gland 
in mammals is not; rather, it works as a “slave oscillator” that generates rhythmic output solely 
through its innervation by the SCN. Arguably one of the most important outputs of the pineal 
gland in mammals is that of melatonin – the SCN not only drives rhythmic melatonin synthesis 
in the pineal gland but also has receptors for melatonin itself, allowing for a feedback effect that 
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controls the phase of the rhythm (River-Bermudez et al., 2004; Bedrosian et al., 2013). 
Melatonin’s main role in the circadian system is that of coordinating synchrony and phase in the 
divergent population of SCN clock cells, which all have slightly different free-running period 
lengths. Other synchronizing agents include the glutamatergic fibres originating from the retina, 
serotonergic fibres emanating from the raphe nuclei, NPY fibres coming from the intergeniculate 
leaflet, and other hormonal/metabolic signals. For a more in-depth discussion on melatonin, see 
section 1.3.  
 Of particular interest to chronobiologists is the fact that clock genes are not only 
expressed rhythmically in structures within the central nervous system (including but not limited 
to the cerebellum, hippocampus, arcuate nuclei, paraventricular hypothalamic nuclei, piriform 
and cerebral cortices, olfactory bulbs, amygdala, retina, and pineal gland), but also in several 
peripheral tissues such as the liver, pancreas, fat, gut, lung, and heart (Abe et al., 2002; Challet et 
al., 2003; Schibler et al., 2003; Amir et al., 2004; Gachon et al., 2004; Verwey and Amir, 2009; 
Mendoza et al., 2010). It is of importance to note that cells expressing clock genes are not 
necessarily clocks – the expression of clock genes must oscillate and undergo circadian cycling 
in the absence of external cues for it to be considered a genuine clock. Thus rhythmicity in the 
above-mentioned peripheral tissues originates from cellular clocks within the tissues themselves. 
Though the exact role of molecular oscillations for the function of peripheral organs is still 
unclear, it has been hypothesized that it either allows the organ to anticipate signals coming from 
the SCN, or it enables the organ to maintain robust rhythmicity by enhancing the signals (Pevet 
et al., 2006). Regardless of the reason, these central and peripheral oscillators work together to 
form an integral part of what is now known as the multi-oscillatory circadian network.  
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1.2 The Hormone Melatonin 
 
1.2.1 The Signal of Night: Melatonin Synthesis and Control 
 
 Melatonin, also known as N-acetyl-5-methoxytryptamine, was first isolated in 1958 from 
bovine pineal gland (Lerner et al., 1960). The rise of pineal melatonin content during the night 
and the subsequent fall during the day was among the first physiological rhythms to be 
characterized as a true circadian rhythm (Ralph et al., 1971). This melatonin rhythm is now one 
of the most well-defined and well studied endogenous circadian rhythms to date. In mammals, 
the synthesis of pineal melatonin is driven by the SCN clock. Melatonin is synthesized from the 
amino acid tryptophan which is converted into 5-hydroxytryptophan by tryptophan-hydroxylase 
and then by decarboxylation into serotonin. From there, the metabolism of serotonin occurs in 
two steps. In the first step, arylalkylamine N-acetyltransferase (AANAT) catalyzes the 
conversion of serotonin to N-acetylserotonin, which is then O-methylated (the transfer of a 
methyl group from 5-adenosylmethionine to the 5-hydroxy group of N-acetyleserotonin) by 
hydroxyindole-O-methyltransferase (HIOMT) to form melatonin (Schomerus and Korf, 2005). 
Melatonin is not stored within the pineal but, following synthesis, is immediately released into 
the circulating blood stream where it has a relatively short half-life as it is rapidly 6-hydroxylated 
in the liver. Therefore, the rhythm of melatonin in the peripheral circulation reflects its rhythmic 
synthesis by the pineal. The enzyme AANAT mediates the rate-limiting step in melatonin 
synthesis and is responsible for generating the circadian rhythm of melatonin production. The 
presence of AANAT in pineal cells is regulated by the release of norepinephrine (NE) from the 
sympathetic nerve fibres originating from the SCN and innervating the pineal parenchyma, 
which release NE in a circadian manner during the night (Kalsbeek and Buijs, 2002; Moller and 
Baeres, 2002). The release of NE elevates intracellular cyclic AMP (cAMP) concentrations and 
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activates cAMP-dependent protein kinase A, allowing AANAT to be phosphorylated and thereby 
protecting it from degradation (Kalsbeek and Buijs, 2002). During the day, in the absence of NE 
stimulation, AANAT is immediately broken down by proteasomal proteolysis. Thus, melatonin 
levels are elevated during the night as AANAT is available for the metabolic conversion of 
serotonin to melatonin, but not during the day as AANAT is destroyed in the absence of 
noradrenergic stimulation. 
 The SCN directly drives the synthesis of melatonin through a multi-synaptic neural 
pathway which includes the pre-autonomic neurons of the paraventricular nucleus (PVN) of the 
hypothalamus, the sympathetic pre-ganglionic neurons of the spinal cord, and the noradrenergic 
sympathetic neurons of the superior cervical ganglion (Moore, 1996 a & b; Larsen et al., 1998; 
Teclemariam-Mesbah et al., 1999). Early studies on the SCN’s control of melatonin synthesis 
and release found gamma-aminobutyric acid (GABA) present in the neurons of the SCN 
(Okamura et al., 1989; Moore and Speh, 1993; Buijs et al., 1994). As light exposure causes 
activation of most SCN neurons, it was thought that GABA could be released from the SCN 
terminals as a response to light-induced activation of these neurons, in turn inhibiting the release 
of melatonin (Groos and Meijer, 1985). Kalsbeek et al. (2000) confirmed this hypothesis, finding 
that nocturnal light exposure causes the release of GABA in the vicinity of the PVN, inhibiting 
the PVN neurons that control the final part of the pineal-activating pathway. Moreover, it has 
been postulated that GABA may be released from the SCN terminals according to an 
endogenous circadian rhythm, and may even be partially responsible for the circadian rhythm of 
melatonin release. Though still up for debate, this hypothesis has been substantiated by studies 
that found that infusion of a GABA antagonist into the PVN of mice during the subjective day 
provoked the release of melatonin, with melatonin concentrations reaching nighttime levels at 
! 12 
the end of a 4 hour infusion (Kalsbeek et al., 2000; Perreau-Lenz et al., 2003). Further evidence 
for this hypothesis has come from studies by Perreau-Lenz et al. (2004, 2005), demonstrating 
that the SCN uses a combination of rhythmic daytime inhibitory signals (via release of GABA) 
and nighttime stimulatory signals (via release of glutamate) to control the daily rhythm of 
melatonin synthesis. Therefore, the presence of glutamate and the absence of GABA during the 
night activates the PVN neurons and stimulates the noradrenergic sympathetic neurons to release 
NE, in turn raising the levels of AANAT and allowing for the synthesis of melatonin from 
serotonin. 
 
1.2.2 Role of Melatonin in the Circadian System 
 
 Melatonin serves as the “hormone of darkness” in the circadian system, relaying timing 
information and synchronizing the “central clock” in the SCN with the peripheral clocks 
scattered throughout the body (Hardeland et al., 2011; Pevet and Challet, 2011). As an output of 
the SCN clock, the nocturnal secretion of melatonin is able to distribute a circadian message to 
the entire body. The duration of melatonin secretion and the corresponding levels of melatonin in 
the circulating bloodstream reflect the length of the night and indicate a relative position within 
the 24 hour day. Therefore, the daily profile of melatonin secretion conveys internal information 
used not only for circadian timing, but also for seasonal temporal organization. Thus, changes in 
the duration of melatonin production throughout the year can be integrated by the brain to 
measure photoperiodic time. Though the role of melatonin in photoperiodic responses has been 
widely documented in animal models (for comprehensive reviews of photoperiodism in animals, 
see Bradshaw and Holzapfel, 2007 and Hazlerigg, 2012), there is little evidence of photoperiodic 
phenomena in humans and thus this role of melatonin will not be discussed within the framework 
of this thesis. 
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 Three melatonin receptor subtypes have been identified, two of which are currently 
known to be found in mammals (MT1 and MT2 subtypes). Though both MT1 and MT2 subtypes 
are G protein-coupled receptors, they play different roles in the mammalian system. Activation 
of MT1 receptors inhibits neuronal firing and induces arterial vasoconstriction, while activation 
of MT2 receptors phase shifts circadian rhythms generated within the SCN and induces 
vasodilation (Dubocovich and Markowska, 2005). Both receptor subtypes have been localized 
within the central nervous system and in peripheral tissues of mammals. Though melatonin is 
ubiquitous in animals and potential target sites are numerous, binding sites have been reported to 
vary widely across mammalian species (Masson-Pevet et al., 1994; Morgan et al., 1994). Of the 
several dozen sites studied within the brains of animal models such as rats, Syrian hamsters, 
Siberian hamsters, white-footed mice, guinea pigs, rabbits, goats, sheep, vervet monkeys, 
baboons, rhesus monkeys, and humans, only the SCN and pars tuberalis of the pituitary showed 
consistency across all models. In humans, MT1 receptor proteins have been found in Brodmann’s 
area 10, putamen, caudate nucleus, nucleus accumbens, substantia nigra, amygdala, and 
hippocampus of the post-mortem human brain (Uz et al., 2005). The identification and 
localization of these receptors holds much importance as it allows for targeted regions of interest 
in which exogenous melatonin’s effect on the human brain can be examined.  Outside of the 
brain, animal and human melatonin binding sites have been characterized to include the spleen in 
guinea pigs, hamsters, mice, ducks, and pigeons, the ovaries and testes in chickens, the kidneys 
in ducks, and the spermatozoa in humans (Morgan et al., 1994). This widespread distribution of 
melatonin receptors both within and outside of the nervous system makes it the key agent to 
deliver circadian timing information throughout the body, and may play a role in the entrainment 
of peripheral oscillators in these tissues (Alonso-Vale et al., 2008; Brodsky and Zvezdina, 2010; 
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Chakravarty and Rizvi, 2011).  
 
1.2.3 Melatonin as an Antioxidant 
 
 Melatonin plays a second crucial role in mammals: it helps to rid the body of free 
radicals, as it is one of the most powerful antioxidants found in humans (Vijayalaxmi et al., 
1998). Due to melatonin’s amphiphilic properties, it can cross physiological barriers that other 
antioxidants possessing only hydrophilic or lipophilic properties cannot. It is for this reason that 
melatonin is such a powerful antioxidant, as it is able to reduce oxidative damage in both the 
lipid and aqueous environments of cells (Reiter et al., 2004). Direct antioxidant properties of 
melatonin have been shown to occur through protection against DNA degradation and lipid 
peroxidation (Bonnefont-Rousselot and Collin, 2010). It is thought that protection against DNA 
degradation by melatonin may be due to the direct scavenging of free radicals along with the 
activation of DNA repair enzymes (Vijayalaxmi et al., 1998). Indeed, several studies have 
demonstrated the ability of melatonin to scavenge oxygen-derived free radicals, including 
hydroxyl free radicals (Poeggeler et al., 2002; Roberts et al., 1998; Matuszak et al., 1997) and 
peroxyl free radicals (Livrea et al., 1997; Pieri et al., 1994). Furthermore, melatonin has been 
shown to exhibit an indirect antioxidant role by supporting superoxide dismutase and glutathione 
peroxidase activity (Korkmax and Reiter, 2008). Reiter et al. (2002) and Winiarska et al. (2006) 
found that melatonin activates γ–glutamylcysteine, stimulating glutathione production in cells 
and thereby increasing glutathione levels. In addition, it was found that melatonin promotes the 
activity of glutathione reductase, which converts oxidized glutathione back to its safer, reduced 
glutathione form (Reiter et al., 2002). Thus disturbances to the melatonin rhythm cause not only 
circadian disruption but also reduce antioxidant levels, which in turn, increases the risk of 
developing diseases. 
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1.2.4 Melatonin as a Chronobiotic 
 
 When it was first discovered that the SCN not only drives rhythmic output of melatonin 
but has receptors for melatonin itself, scientists were puzzled as to why this was the case. It has 
now been shown that circulating melatonin is able to feed back onto the SCN clock, affecting 
circadian regulation as demonstrated by the phase-shifting effects on the firing rate of SCN 
neurons (Gillette and McArthur, 1996). As such, research has now focused on the use of 
melatonin as a chronobiotic – a drug that shifts all circadian rhythms in a desired direction 
(advance or delay) and acts as a Zeitgeber (German word for “time giver”, referring to cues or 
signals that clocks synchronize to) to maintain a stable phase once the desired shift has been 
obtained. 
 It has long been known that daily administration of melatonin acts on activity rhythms in 
rodents – studies using subcutaneous injections, infusions, or melatonin administered via 
drinking water all demonstrated the ability to entrain free-running rhythms in rats (Redman et al., 
1983; Pitrosky et al., 1999; Slotten et al., 1999). According to the non-parametric model of 
entrainment, this synchronization process occurs through progressive daily phase shifts. In 
respect to melatonin, researchers studying its entrainment limits have concluded that daily phase 
shifts as a result of exogenous melatonin range from a minimum of half an hour to a maximum 
of an hour and a half (Slotten et al., 2002). When administered to humans in accordance with the 
melatonin phase response curve (PRC) first documented by Lewy et al. (1998), which illustrates 
the relationship between the time exogenous melatonin is taken and the effects it has on the 
rhythm, it can produce phase advances that reset the circadian clock to an earlier time, or phase 
delays that reset the circadian clock to a later time. The most current melatonin PRC 
demonstrates that while exogenous melatonin administered around the time of endogenous 
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melatonin secretion causes little phase resetting, exogenous melatonin administered at least two 
hours prior to endogenous melatonin secretion causes phase advances and exogenous melatonin 
administered at least two hours after endogenous melatonin secretion causes phase delays 
(Breslow et al., 2013) 
 Melatonin appears to have a dual effect on the molecular machinery of clock cells, as it 
has been observed that Cry1 mRNA expression peaks during the night when blood plasma 
melatonin levels are high and Per1 mRNA expression peaks early in the day when melatonin 
levels in the bloodstream are low (Pevet et al., 2006). It therefore appears that Per1 expression is 
linked to the decline in melatonin levels, while Cry1 expression is gated by its release. However, 
Poirel et al. (2003) observed that administration of exogenous melatonin did not alter 
transcriptional regulation of the clock genes Per1, Per2, Clock, Bmal1, Cry1 and Cry2 in rats. It 
was thus concluded that these genes are not the initial target that mediates melatonin-induced 
phase advances or delays, and that the chronobiotic effect must lie elsewhere and rely on other 
regulatory mechanisms. In support of this conclusion, Agez et al. (2007) found that acute 
injected melatonin induced an immediate phase advance of the expression rhythm of REV-
ERBα, a nuclear receptor that acts as a transcriptional repressor. This finding suggests that this 
transcription factor, and not the clock genes themselves, may be the primary molecular target 
involved in the chronobiotic effect of melatonin (Agez et al., 2007).  
 The chronobiotic properties of melatonin may help to explain the wide range of its 
reported effects – for example, improved cardiovascular, digestive and immune functions – and 
demonstrates that it may be suitably used as a pharmacological drug to manipulate circadian 
rhythms. Indeed, melatonin has been shown to help shift workers entrain to their schedule, thus 
improving their sleep duration and quality (Zee and Goldstein, 2010). Furthermore, documented 
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responses to administration of exogenous melatonin have validated its efficacy in both 
advancing and delaying the circadian clock and its resulting rhythms, providing evidence for the 
use of melatonin to help shift workers entrain to their work schedule (Folkard et al., 1993; 
Burgess et al., 2002; Burgess et al., 2008; Burgess et al., 2010; Zee and Goldstein, 2010). The 
most convincing data to be obtained thus far, however, have come from studies on blind 
individuals, who often experience sleep disturbances because their activity rhythms can fall out 
of phase with social cues for sleeping and wakefulness. Exogenous melatonin administered 
daily has been shown to entrain the sleep/wake cycle of these individuals to a 24 hour period, 
resulting not only in a stable sleep/wake rhythm but in improvements to their quality of life as 
well (Skene and Arendt, 2006 and 2007). 
 
 
1.3 Our 24/7 World: Circadian Disruption and its Consequences 
 
1.3.1 Temporal Disruption and Desynchronization 
 
 In today’s 24/7 world, shift work has become increasingly commonplace to meet 
society’s ever-increasing demands. Although shift work has long been associated with minor 
health problems such as gastrointestinal disorders, abnormal metabolic responses, and sleep 
disorders, the more serious risks to long-term shift workers are only recently coming to light 
(Arendt, 2010). Of the major diseases that have been found to afflict shift workers, the two most 
well documented associations are between shift work and cardiovascular disease, and female 
shift workers and breast cancer (Arendt, 2010). Shift workers have been reported to have an 
increased risk for developing cardiovascular disease and its associated health problems (Peter et 
al., 1999), including obesity, high triglyceride levels, and low high-density lipoprotein (HDL) 
cholesterol concentrations among other metabolic abnormalities (Al-Naimi et al., 2004; Karlsson 
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et al., 2001, 2003). It has also been shown that women who work on a rotating night shift 
schedule have a 36% greater chance of developing breast cancer than women who have never 
worked rotating shifts, with the risk rising further as the duration of participation in shift work 
increases (Schernhammer et al., 2001). The epidemiological evidence correlating work-related 
temporal disruptions and breast cancer have been so convincing that in 2008, Denmark officially 
recognized shift work as an occupational hazard and as a result, became the first country to pay 
government compensation to women who developed breast cancer while working long-term 
night-shifts (Chustecka, 2009).  
 These health problems are manifestations of a breakdown of the circadian timing system, 
and as this vital system is important for proper physiological function disruption is expected to 
produce serious effects. Thus shift workers working out of phase with their internal biological 
clock undergo what is known as internal desynchronization – a state in which the body’s internal 
clocks are out of synchrony with each other and with the external environment (Arendt, 2010). 
As much of the lives of shift workers are spent out of phase with local time due to their 
constantly changing shift schedules, their circadian clocks often cannot completely readjust their 
circadian rhythms, resulting in a state of permanent internal desychronization. In a similar 
manner, those who suffer from jet lag experience the unpleasant effects of undergoing circadian 
disruption. Flying across different time zones produces a misalignment of the body’s multiple 
internal clocks with each other and between them and the external environment. Over time, the 
clocks will resynchronize with each other and the outside world and the jet lag symptoms will 
subside. Under normal circumstances, experiencing jet lag does not pose a serious health risk; it 
does, however, become an issue of concern when dealing with those working as pilots, co-pilots, 
and flight attendants. With the growing awareness of these potential issues, the aviation industry 
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has made efforts to combat the effects of internal desynchronization by attempting to minimize 
the impact of jet lag on flight crews that cross many time zones. 
 One of the main problems afflicting workers who participate in rotating/night shifts is the 
exposure to light at night, the occurrence of which disrupts normal circadian physiology and 
behavioural rhythms. As mentioned in section 1.1.2, light is detected by photoreceptive ganglion 
cells in the eye, projecting down the RHT and entraining the clock cells within the SCN. These 
SCN clock cells control melatonin synthesis in the pineal gland, and therefore exposure to 
extended periods of light at night can drastically alter melatonin levels (Reiter et al., 2011). 
Disruption of this melatonin rhythm, a crucial part of the mammalian circadian timing system, 
can evoke a multitude of downstream events including altering the rhythmicity of release of 
several hormones (e.g., prolactin, glucocorticoids, and serotonin) (Stevens et al., 2009; Reiter et 
al., 2011; Gaston et al., 2013), eventually leading to the development of the health problems 
mentioned above. Thus understanding the link between temporal disruption and 
desynchronization and finding ways to minimize disruption of the circadian system is a crucial 
step in reducing the adverse effects of shift work and jet lag. 
 
1.3.2 Light at Night and Human Health 
 
 Almost all manifestations of health problems associated with circadian disruption stems 
from the extended exposure to light at night. It has been found that it takes only 39 minutes of 
human exposure to a low-level incandescent light bulb during nighttime to suppress melatonin 
levels by 50% (Schulmeister et al., 2004). At the cellular level, constant light-induced 
interruption of nightly melatonin secretion has been shown to affect basic processes associated 
with the acquisition and utilization of energy, functionally altering the regulation of body mass, 
the efficiency of gut metabolism, and the synthesis of adenosine triphosphate (ATP) in the heart 
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(Navara and Nelson, 2007). Exposure to light at night has also been demonstrated to affect 
insulin resistance, carbohydrate and lipid metabolism, hypertension, coronary heart disease, and 
myocardial infarction (Haus and Smolensky, 2006). Of all these health problems, none have been 
more extensively studied than those of coronary heart disease and cancer. 
 As of 2012, diseases of the heart are the second leading cause of death in Canada 
(Statistics Canada, 2012), with only cancer outranking it in the number of deaths per year. As 
such, much research has been directed towards revealing the underpinnings of the association 
between shift work and heart disease. Knutsson et al. first reported in 1986 that shift workers 
have a 40% increased risk of developing heart disease compared to non-shift workers. Several 
hypotheses have since been put forth in an attempt to explain this purported link, including the 
stress of shift work disturbing normal metabolic and hormonal functions (Harma, 2006), and the 
high percentage of shift workers that engage in health-adverse behaviours such as smoking, 
drinking, and having a poor diet (Zhao and Turner, 2008). Most notable, however, has been the 
discovery that depressed melatonin levels due to exposure to light at night have negative effects 
on the heart. Bulloguh et al. (2006) found that melatonin reduces the activity of the sympathetic 
nervous system and in turn, significantly reduces norepinephrine turnover in the heart. Melatonin 
is thus beneficial as norepinephrine and epinephrine have both been shown to accelerate the 
uptake of low-density lipoprotein (LDL) cholesterol. Shift workers may therefore be at an 
increased risk of developing cardiovascular disease as their melatonin levels are consistently 
low, resulting in over-activity of the sympathetic nervous system, increased levels of 
norepinephrine, epinephrine and LDL cholesterol, and decreased levels of HDL cholesterol over 
time.  
 A growing number of studies have also suggested that internal desynchronization may 
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play a key role in the occurrence of endocrine malignancies. The association between disrupted 
circadian rhythms and the increased rates of cancer has been reported to be due to two main 
processes: the direct actions of depressed melatonin levels and the secondary endocrine 
modulations resulting from light exposure and/or sleep disruption. Davis et al. (2012) found 
disturbances in the endogenous sex hormone concentrations of women working night shifts 
compared to those working day shifts, with night shift working women having elevated levels of 
follicle stimulating hormone and luteinizing hormone during both night work and daytime sleep 
compared to day shift working women during nighttime sleep. Indeed, alterations of endogenous 
sex hormone levels have been well established as being a risk factor for developing breast 
cancer, the most common type of cancer to afflict women shift workers. On the other hand, the 
melatonin hypothesis suggests that reduced pineal melatonin secretion may increase the risk of 
breast cancer by interacting with high levels of estrogen, a known promoter of breast tissue 
proliferation (Anisimov et al., 2004). Melatonin is thought to have a protective effect as it has 
been shown to prevent the proliferation of tumor cells by shifting the cell balance from 
proliferation to differentiation, and has also been shown to promote the apoptosis of cancer cells 
(Navara and Nelson, 2007). In addition, melatonin has been reported to provide protection 
against cancer development by inhibiting the cell growth of breast cancer cells expressing 
estrogren receptors (Sanchez-Barcelo et al., 2012). Though the exact role of melatonin in relation 
to these health problems is still unclear, there continues to be an increasing number of studies 
that support the link between the melatonin hypothesis and shift work. 
 
 
1.4 The Circadian System and Cognitive Processes 
 
1.4.1 Circadian Rhythm of Learning and Memory 
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 The ability to consciously exert control over one’s cognitive performance is dependent 
upon the combined action of three processes: the circadian process, the homeostatic process, and 
sleep inertia (Golombek et al., 2013). As various cognitive functions throughout the day are 
regulated by the circadian system, cognitive ability may be impaired if the circadian system is 
disrupted. One such example is the decrease in cognitive performance due to internal 
desynchronization. Several studies using both animal and human models have demonstrated an 
influence of circadian timekeeping on learning and memory (Tapp and Holloway, 1981; Cho et 
al., 2000; Cho, 2001; Ralph et al., 2002). In particular, it has been shown that chronic phase 
shifts of the light/dark cycle affect memory in rats and mice (Devan et al., 2001; Loh et al., 
2010). Moreover, induced circadian disruption in adult female hamsters was demonstrated to 
suppress hippocampal neurogenesis, leading to drastic and persistent impairments in learning and 
memory (Gibson et al., 2010). Similarly, deficits in learning and memory in humans have been 
observed in chronically jet-lagged flight attendants (Cho et al., 2000; Cho, 2001). Other studies 
on people whose circadian rhythms have been disrupted as a consequence of night or shift work 
have also shown changes in cognitive efficiency. For example, it was documented that shift 
workers had cognitive impairments that included slowed/delayed reaction times (RT), increased 
error rates, reduced vigilance, memory impairments (including problems with verbal memory), 
poor motivation, increased performance variability, reduced subjective alertness, and lower 
subjective well-being scores (Dijk et al., 1992; Horowitz et al., 2001; Santhi et al., 2007 and 
2008).  
 Although circadian desynchronization has been documented on multiple occasions to 
transiently impair several cognitive performance, the exact way in which this occurs is currently 
not well understood. Kiessling et al. (2010) hypothesized that perturbations of cognitive function 
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may be due to the misalignment of the transcriptional feedback loops driving the molecular 
clock, as circadian disruption (and jet lag in particular) is characterized by the non-uniform phase 
resetting of genes that operate in both the positive and negative feedback branches of the clock. 
In 2005, Rouch et al. found that among former shift workers who had stopped shift work for 
over 4 years, cognitive performance seemed to improve, suggesting a possible reversal of the 
detrimental effects of shift work. If Kiessling and colleagues’ hypothesis is true, Rouch et al.’s 
findings may indeed be a result of the gradual realignment of the feedback loops in the molecular 
clock, a scenario that is not too farfetched as the body’s clocks undergo a similar 
resynchronization process when recovering from jet lag. In reality, though, shift work is 
necessary to sustain the world in which we live; thus, developing effective treatments for 
circadian disorders may be an important strategy for improving the social aspects related to 
internal desynchronization and cognitive deficiencies, including increasing public safety, health, 
well-being, and productivity. 
 
1.4.2 Neural Correlates of Attention and Inhibition 
 
 The ability to focus attention and plan goals and behaviours accordingly is pertinent to 
the survival of mankind in this multifaceted world. Just as important, however, is the ability to 
suppress inappropriate and misguided actions when faced with ambiguous stimuli. Often times, 
situations arise in which complex decision-making strategies and coordination of actions are 
required – for example, when faced with competing demands and more than one response option 
(Behrens et al., 2007; Cisek et al., 2009). A commonly used experimental task that embodies 
such a situation is the Stroop task, first developed by J. Ridley Stroop in 1935. In the Stroop task, 
participants are asked to name the colour of the ink that a colour word is written in (Stroop, 
1935). Use of these variables allows for two possible conditions – one in which the ink colour 
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and the written word match, and one in which the ink colour and the written word do not match. 
What is known as the Stroop effect occurs when the name of a colour is printed in a colour not 
denoted by the word (i.e. when the word “blue” is written in red ink), creating a conflict situation 
between what is automatically read and what response must be given (Stroop, 1935). Participants 
must therefore inhibit the prepared response of reporting the written word and instead direct 
attention to the less habitual response of reporting the ink colour, with the result being an 
increased amount of errors and longer RTs as compared to situations in which no conflict is 
present (i.e. when the word “blue” is written in blue ink). 
 An altered version of the Stroop task, known as the emotional Stroop task, uses affective 
face/word combinations rather than the original Stroop colour/word combinations to create 
interference situations in which a prepotent response must be inhibited to give a correct answer. 
Such incongruent conditions, whereby the facial emotion does not match the superimposed 
affective word (i.e. a happy face with the word “sad” written over top), have also been shown to 
elicit the well-documented Stroop effect. It has previously been demonstrated in both the Stroop 
and emotional Stroop tasks that processing of word reading occurs faster than the processing of 
colour naming or identifying facial expressions (Stroop, 1935; Ovaysikia et al., 2011). Thus in 
conflict situations inhibition processes resulting from top-down control must be exerted to inhibit 
the automatic nature of reading out the word – a difficult process that has consistently been 
shown to be more prone to errors (Ovaysikia et al., 2011). 
 Previous research on higher cognitive functions has shown the prefrontal cortex to be 
implicated in response suppression and selection (Miller, 2000; Miller and Cohen, 2001). More 
specifically, the inferior frontal gyrus (IFG), an area that has been reported to play a key role in 
language production and response inhibition, was found to exhibit strong lateral activation 
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during incongruent blocks in both the expression (“report the facial emotion”) and word (“report 
the written word”) instruction conditions of the emotional Stroop task (Ovaysikia et al., 2011). 
Additionally, unpublished data from a study performed by DeSouza et al. (2003) demonstrated 
strong bilateral activation of the basal ganglia, specifically the putamen, in participants 
performing an anti-saccade task. In line with findings from the emotional Stroop task, inhibitory 
(anti-saccade) blocks of this task resulted in greater activation of the basal ganglia than the 
reactionary (pro-saccade) blocks (DeSouza et al., 2003). Other regions of the brain, namely the 
amygdala and associated limbic structures, have been shown to be activated in response to 
affective facial expressions and emotionally salient words (Egner et al., 2008). One particular 
limbic structure of interest to the current work is the hippocampus. Beyond its role in processing 
affective faces and words, the hippocampus has been reported to be involved in the consolidation 
of information from short- to long-term memory (Squire, 1992; Sutherland et al., 2001; 
Eichenbaum et al., 2007), and has also been well documented to be involved in spatial 
navigation (Morris et al., 1982; Sutherland et al., 1982; Jarrard, 1993; Maguire et al., 1998; 
Maguire et al., 2000; Clark et al., 2004; Shrager et al., 2007). These above-mentioned brain 
regions are of importance not only because they have been implicated in the inhibition network 
as well as in the processing of emotion, but also because they have been characterized to have a 
high concentration of both MT1 and MT2 receptor subtypes in animals and humans alike 
(Morgan et al., 1994; Uz et al., 2005). These brain areas therefore act as ideal regions of interest 
(ROI) for functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) 
analyses, as they combine the study of circadian dysfunction with cognitive performance on the 
emotional Stroop task.   
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1.5 Diffusion Tensor Imaging as a Tool for Neural Structural Analysis 
 
1.5.1 DTI Metrics: Fractional Anisotropy, Mean Diffusivity and Fibre Count 
 
 Diffusion tensor imaging (DTI) is a non-invasive magnetic resonance imaging technique 
that maps the in vivo diffusion process of water molecules in biological tissue. First used in the 
mid-1980s, DTI has now gained acceptance in the field as it allows for a better understanding of 
the brain’s structural connectivity through the reconstruction of its major fibre bundles and the 
production of neural tract images. DTI measurements provide indication of the brain’s structure 
as water diffusion depends on tissue architecture – that is, water diffuses more freely if there is 
more space between obstacles such as neurons, glial cells, and blood vessels, while less space 
between these obstacles as a result of cells or blood vessels increasing in size or number results 
in more restricted diffusion (Le Bihan et al., 2001; Hagmann et al., 2006; Jones et al., 2012). 
During image acquisition, a diffusion gradient is applied that produces a random distribution of 
proton spin phases and results in an attenuated signal amplitude. The amount of signal reduction 
depends on the strength of the gradient (known as the b-value), as well as the direction that the 
gradient is applied. In order to model diffusion in three-dimensional space, a tensor ellipsoid 
with three perpendicular axes (known as eigenvectors) and three distinct diffusion coefficients 
(known as eigenvalues) must be constructed by applying a minimum of 6 gradient directions, 
although current practice generally dictates the use of 30 or 64 directions. With the ellipsoid 
fitted, DTI measurements can then be obtained from each voxel (also known as a volumetric or 
3-dimensional pixel) that reflect the average amount of restriction experienced by water 
molecules moving along the axis of the applied gradient (Jones et al., 2012; Soares et al., 2013). 
 DTI analysis consists of four main measurements: fractional anisotropy, mean diffusivity, 
axial diffusivity, and radial diffusivity. Fractional anisotropy (FA) is a normalized scalar measure 
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used to characterize the degree of anisotropic diffusion (Soares et al., 2013). It is important to 
note that no directionality can be inferred from FA values alone. Directional information can 
only be deduced by examining colour-coded FA maps that have specific colours assigned to 
specific orientations – for example, red representing left-to-right orientation, green representing 
posterior-to-anterior orientation, and blue representing inferior-to-superior orientation (Soares et 
al., 2013). FA is calculated by dividing the square root of the sum of squares of the diffusivity 
differences by the sum of squares of the diffusivities and multiplying the division score by 1/√2 
for normalization (Soares et al., 2013). When the diffusion coefficients of the second and third 
axes are small relative to the principle axis, the number in the numerator is almost equal to the 
number in the denominator and the resulting FA value is close to 1. An FA value of 1 represents 
purely anisotropic diffusion, or diffusion occurring only along the principle axis. Conversely, 
when the diffusion coefficient of the second and third axes are large relative to the principle axis, 
the number in the numerator is much smaller than the number in the denominator, resulting in an 
FA value that is close to 0. An FA value of 0 represents purely isotropic diffusion, or diffusion 
occurring along all possible axes. Hence in the brain, FA values are generally lowest in areas 
containing cerebral spinal fluid as there is little present to restrict diffusion, and highest in areas 
of dense white matter as tightly packed neurons greatly minimize the possible diffusion 
directions. Mean diffusivity (MD), also known as the apparent diffusion coefficient, is a scalar 
measure used to describe the rate of diffusion, regardless of direction (Soares et al., 2013). MD 
values are calculated as the mean of the three eigenvalues (represented as λ1, λ2, and λ3), and are 
represented in units of m2/s (Soares et al., 2013). Axial diffusivity represents the major 
eigenvalue of the ellipsoid diffusion tensor, and is the diffusion coefficient that signifies 
diffusivity along the principle axis (Soares et al., 2013). Lastly, radial diffusivity is the average 
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of the two remaining eigenvalues, and is the average of the diffusion coefficients that represents 
diffusivity along the two minor axes (Soares et al., 2013). 
 These DTI measurements are not all that can be inferred from the raw data – a technique 
known as probabilistic tractography can also be used to model fibre orientations in the brain, thus 
providing more information on white matter microstructure. Probabilistic tractography recreates 
fibres thought to represent the axons of neurons by starting at a region called the seed region and 
checking to see whether adjacent voxels have a principal eigenvector in line with the previous 
voxel (Hagmann et al., 2006; Jones et al., 2012). If so, the process is repeated, with the outcome 
being that a neural tract emanating from the seed region and terminating at a secondary location 
in the brain is inferred. Beyond visually displaying these tracts, tractography also produces a 
connectivity index along a white matter pathway called a streamline count (SC) that reflects fibre 
orientation and represents the possible number of valid tracks from a particular point, or between 
two points in the brain. These SC values can vary widely from brain region to brain region, as 
well as from person to person. It is important to note that changes in the above-mentioned DTI 
measurements have clearly been demonstrated to be correlated with changes in brain architecture 
and white matter microstructure (for a review of white matter modeling, see Nilsson et al., 
2013). 
 As DTI is a relatively new technique, the literature remains largely focused on its use in 
pathology. Only one peer-reviewed article could be found on DTI that pertained to circadian 
rhythms, and as such the next section will discuss this article in more detail.  
 
 
1.5.2 DTI and Chronotypes 
 
 Chronotypes refer to endogenous dispositions in humans that are categorized according to 
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the circadian phase of the biological clock and therefore reflect preferences in circadian rhythms 
(Kerkhof and Van Dongen, 1996; Katzenberg et al., 1998). Though the term chronotype 
encompasses a wide range of cognitive (e.g., efficiency and alertness) and physiological 
functions (e.g., hormone levels and body temperature), its use commonly refers to sleep and 
wake habits alone. Thus, those who wake up early, are most alert in the first part of the day, and 
have difficulty staying up late are referred to as morning people, larks, or early chronotypes 
(EC); those who sleep late into the day, are most alert in the late evening hours, and go to bed 
late are referred to as evening people, owls, or late chronotypes (LC). It has been shown that LCs 
have a large discrepancy between individual sleep preferences and normal day to day schedules, 
such as in a 9-to-5 working world (Roenneberg et al., 2003). As such, deficits in sleep often 
accumulate over the week, leading to reports of poor sleep quality, tiredness, and psychological 
disturbances (Giannotti et al., 2002). In addition, LCs have been found to consume more legal 
stimulants (such as nicotine and alcohol) than ECs (Giannotti et al., 2002). It has been postulated 
that LCs exhibit a chronic form of functional jet lag, as their endogenous sleep/wake rhythms do 
not fit conventional societal schedules (Wittmann et al., 2006). As a result of this long-term 
desychronization between LCs’ endogenous rhythms and the external environment, 
physiological impairments arise and stress is induced due to increased cortisol levels (Cho, 
2001). Evidence of structural changes in the brain have been found in people exposed to high 
levels of cortisol for five years, and cognitive deficits as a result of temporal lobe atrophy have 
also been demonstrated in those suffering from chronic jet lag (Cho, 2001). Thus, Rosenberg et 
al. (2014) aimed to deduce whether chronic differences in sleep preferences due to chronotype-
specificities are associated with structural differences in the brain, and whether chronotype-
specificity and health-impairing behaviour are associated with specific neural mechanisms. 
! 30 
 Using a 30 direction DTI scan, Rosenberg and colleagues (2014) collected data from 16 
healthy male ECs and 23 healthy male LCs between the ages of 18 and 35. They hypothesized 
that LCs would differ significantly in their lifestyle habits from ECs and that LCs would exhibit 
significantly different DTI metrics than ECs in the anterior cingulate cortex (ACC), corpus 
callosum, frontal lobe, and temporal lobes. Consistent with previous literature and with their 
hypothesis, it was indeed found that LCs consumed significantly more nicotine and alcohol than 
ECs. They reported no significant correlation between alcohol and nicotine consumption and 
significant DTI metrics. It was also found that LCs demonstrated significantly lower FA values 
in the white matter underlying the left ACC, the left frontal lobe, and the left cingulate, and 
significantly higher MD values in the left cerebrum and left frontal lobe compared to ECs. The 
differences between LCs and ECs in ACC and temporal lobe white matter were of particular 
interest, as LCs have been reported to be at a higher risk of developing bipolar disorder and 
depression (characterized by white matter ACC abnormalities) (Wood et al., 2009; Levandovski 
et al., 2011) and chronic jet lag has been found to result in atrophy of the temporal lobe (Cho, 
2001). As such, these significant differences in DTI metrics may be used as an indicator for the 
development of disease and chronic functional jet lag during aging. Although still preliminary in 
nature, this study holds much importance as it is the first published report linking endogenous 
circadian rhythms with structural differences in the brain across ECs and LCs. As the brain is the 
central component of the mammalian circadian timing network, future research in the field of 
circadian rhythms should aim to incorporate neuroscience techniques in order to gain a better 
understanding of the mammalian circadian system as a whole.  
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1.6 Objectives, Research Questions and Hypotheses 
 
 Though much is now known about the use of melatonin to entrain the circadian clock and 
its resulting effects on rhythmical phenomena such as sleep and the daily rise and fall of core 
body temperatures (Arendt 2006), little is known about the effects melatonin treatments may 
have on one’s cognitive abilities. Cognitive impairments as a result of shift work or jet lag have 
only been measured using rudimentary reactionary tasks (Darwent et al., 2010; Zhou et al., 
2011); no studies have used tasks requiring higher cognitive function, nor have any studies 
looked at the resulting effects on the brain. Furthermore, no studies to date have used melatonin 
in an attempt to induce desynchronization in a person’s once synchronous circadian system. This 
study thus aims to answer the following research questions: 
 
1) Can exogenous melatonin administered at inappropriate times mimic the internal 
desynchronization often experience by people participating in shift work or undergoing jet lag, as 
inferred by behavioural and cognitive changes? 
2) Does exogenous melatonin administered at inappropriate times result in deficits in higher 
cognitive function, as measured by performance in an attention-demanding emotional Stroop 
task? 
3) Does exogenous melatonin administered at inappropriate times alter white matter 
microstructure in the brain, specifically in areas associated with higher cognitive function? 
 
It is hypothesized that: 1) sleep and wake cycles will be altered, interpreted to indicate that 
melatonin is an effective agent in shifting participants’ internal clocks out of phase with the 
external environment and with each other; 2) administration of exogenous melatonin will result 
in significantly increased RTs and errors for both instruction sets on the emotional Stroop task; 
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and 3) administration of exogenous melatonin will result in significantly altered DTI metrics, 
particularly in the areas of the IFG and the hippocampus. 
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2. Materials and Methods 
 
2.1 Participants 
 
Ten healthy, right-handed participants (4 males and 6 females, mean age ± SD = 26.8 ± 
6.25 years) were included in this within-subject, single-blind-designed study. All participants 
were screened prior to the start to ensure that they had no history of neurological disorder and 
were free of prescription medication, with the exception being the use of hormonal birth control. 
All participants were fluent in English and had normal or corrected-to-normal visual acuity. All 
procedures and protocols were approved by the York University Human Participants Review 
Subcommittee and Ethics Review board (certificate #2012 – 209). All participants gave their 
informed consent prior to participating in the study and were debriefed accordingly. 
 
 
2.2 Behavioural Procedures 
 
2.2.1 Behavioural Logs and Questionnaires 
 
All participants were asked to keep a log of their daily behaviours for the duration of the 
study, which consisted of a minimum of two weeks prior to the start of baseline testing, during 
the two weeks of baseline testing, and during the eight days of experimental manipulation (see 
Appendix A for a timeline of data collection). These behaviours included their time of waking, 
sleeping, and meals taken, as well as a brief list of activities they participated in throughout the 
day. These behavioural logs were reviewed on an ongoing basis to ensure that all subjects 
exhibited a consistent pattern of behaviours (i.e. that their sleeping, waking, and eating schedules 
did not deviate drastically from day to day). From these logs, participants’ sleep and wake times 
were charted and their dim-light melatonin onset (DLMO) time was estimated by subtracting 2.5 
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hours from their average baseline sleep time. This calculation was based on Martin and 
Eastman’s (2002) work, which demonstrated that healthy adults’ reported sleep times occur 2 to 
3 hours after DLMO. Furthermore, participants were asked to fill out the online Munich 
Chronotype Questionnaire (MCTQ) and to e-mail the resulting PDF file to the researcher when 
completed. These PDF files, which contain the participants’ chronotypes, were taken into 
consideration when analyzing their melatonin profiles (see Appendix B for an example). The 
MCTQ can be found at: 
https://www.bioinfo.mpg.de/mctq/core_work_life/core/introduction.jsp. 
 
2.2.2 Emotional Stroop Task 
 
In order to assess participants’ cognitive abilities, an altered version of Ovaysikia et al.’s 
(2011) emotional Stroop task was used. The emotional Stroop task was chosen as it employs the 
use of two distinctly different components (i.e. a picture of a face and a word) compared to the 
colour/word Stroop task, which only employs the use of word stimuli. Having both faces and 
words thus allowed for better interpretation of the data, as faces and words are processed through 
different pathways in the brain. The emotional Stroop task was coded and presented using 
Presentation 12.1 (Neurobehavioural Systems, Inc., CA, USA). All pictures were taken using a 
Sony DSLRA330L camera. Affective words were superimposed at a 45° angle over the face 
images using Eye Batch 2.1 (Atalasoft Inc., Easthampton, MA, USA) and all images were 
processed to equalize the isoluminance levels. Participants sat at a table with their head placed in 
a head-chin rest during data collection, and the lights in the experimental room were 
extinguished during the data collection period. There were a total of 216 different combinations 
of faces and words (happy, neutral, and sad), with 12 different individual identities. Images were 
presented on a high contrast black background at a visual angle of 12.50° horizontally and 18.66° 
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vertically. Fixation crosses were presented at a visual angle of 2.4° at the center of the screen. 
Prior to administering the task, participants were instructed and underwent a practice session 
consisting of one run with the instruction to “attend and respond to the word” and a second run 
with the instruction to “attend and respond to the face”. The task employed a block-design 
paradigm as follows: (1) an instruction screen appears for ten seconds, reminding participants of 
the instruction previously given as well as indicating the response buttons for the corresponding 
emotions (1 for happy, 2 for neutral, 3 for sad; see Figure 3); (2) 12 pictures are presented in 
succession for two seconds each, during which time participants must process the image on the 
screen and give a response – these 12 pictures make up one block; (3) a fixation cross appears for 
eight seconds, after which the next block of 12 pictures begins; (4) at the end of 15 blocks (five 
congruent blocks and ten incongruent blocks), a final fixation cross appears for 16 seconds, 
indicating the end of a run. The order of blocks was consistent between all runs and participants, 
with the pattern of one congruent block followed by two incongruent blocks being repeated five 
times per run. Each run lasted for a total of 498 seconds, with the starting instruction set (face or 
word) counterbalanced between participants. Participants performed 4 runs of each instruction 
set for each of the baseline and experimental periods, after which the latency of responses 
(reaction time, or RT) and the accuracy of the responses were analyzed using MATLAB version 
7.10 (Natick, MA, USA). RTs and errors were averaged within each of the incongruent and 
congruent conditions separately for the face and word instruction sets. Statistical tests were 
performed using repeated measures ANOVAs on IBM SPSS Statistics version 20 (Armonk, NY, 
USA). This paradigm differed from that of Ovaysikia et al. (2011) in several ways: first, a block-
design with 12 pictures per block was used as opposed to a pseudo-event related design with 6 
pictures per block; second, response images were not used in the current study; third, each 
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picture was presented for a total of two seconds compared to the 250ms presentation previously 
used; and fourth, the fixation crosses appeared for eight seconds instead of one second. All other 
components of the paradigm remained the same. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Example images from the emotional Stroop paradigm. 3 congruent and 3 incongruent pictures 
are shown. 12 congruent or incongruent pictures were displayed for 2 seconds each in their respective 
blocks. Participants were instructed to either attend to and report the facial emotion, or attend to and 
report the written word. Image obtained from Ovaysikia et al., 2011. 
 
 
2.3 Desychronization Protocol 
 
In an attempt to recreate the internal desynchronization that is often experienced by 
people participating in shift work or who suffer from jet lag, eight administrations of 1.5mg 
sublingual melatonin pills were used to shift participants’ internal clocks out of phase with the 
external environment and with each other. Sublingual pills were used in order to deliver the 
melatonin into the blood stream as a Zeitgeber pulse. The pills were prepared by cutting 3mg 
Webber Naturals Melatonin tablets (Coquitlam, BC, Canada) in half, grinding them into a fine 
powder and transferring them into a size 4 gelatin capsule (Pompano Beach, FL, USA). To take 
the pill, participants were instructed to place the pill under their tongue and to keep it there until 
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fully dissolved (approximately five minutes). Each participant was given eight of these pills 
along with a desynchronization protocol consisting of specific times during the day at which they 
were to take the pills (see Appendix C for an example). The desynchronization protocol was 
specific to participants’ daily behaviours as well as to their chronotypes, and consisted of two 
days of taking the pill in the early afternoon and two days of taking the pill in the late morning, 
repeated twice over eight days. This protocol was designed based on a well-established 
melatonin phase-response curve (Lewy et al., 1998) to ensure that participants were fully 
subjected to internal desynchronization, as the melatonin pills were given when melatonin levels 
are generally low. 
 
 
2.4 Biological Samples and Assays (ELISAs) 
 
2.4.1 Saliva Samples 
 
Prior to the start of saliva sample collection, participants were provided with a set of pre-
numbered, 1.5ml graduated microtubes (Diamed Lab Supplies Inc., Mississauga, ON, Canada; 
product number DIATEC610-3168). The numbers on these collection containers matched a 
specifically designed collection protocol that catered to both participants’ chronotype and their 
daily behaviours. This protocol allowed for more sparse collection during daytime hours (when 
melatonin levels are generally very low) (Pandi-Perumal et al., 2006) and more frequent 
sampling starting at a computed DLMO time and through the evening (when melatonin levels 
begin to rise and stay elevated, respectively). Participants were instructed to refrain from eating, 
drinking and brushing their teeth at least 15 minutes prior to starting the collection, as well as to 
rinse their mouths thoroughly with cold water before providing the saliva sample. Participants 
were also instructed to provide a minimum of 1ml of saliva per collection, using the markings on 
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the side of the collection container as reference points (see instructions in Appendix D). During 
the baseline period, participants were asked to provide saliva samples over three days (see 
Appendix E for an example). These saliva samples were refrigerated between 2 – 8°C during the 
week the sampling took place, then placed in a -80°C freezer for storage until assayed. Similarly, 
participants were asked to provide saliva samples over eight days during the experimental period. 
These samples were also refrigerated between 2 – 8°C during the week the sampling took place, 
then placed in a -80°C freezer for storage until assayed. 
 
2.4.2 Enzyme-Linked Immunosorbent Assay 
 
To establish the melatonin profiles of each participant, preliminary enzyme-linked 
immunosorbent assays (ELISAs) were performed to determine the concentration of melatonin in 
two subjects’ baseline saliva samples. However due to unforeseen circumstances regarding 
issues with funding (see Appendix G and H), ELISAs could not be completed for the remainder 
of the collected samples. The ELISA kits used were developed by IBL International and 
distributed by AFFINITY Diagnostics Corporation (Toronto, ON, Canada). The ELISA follows 
a capture antibody technique, whereby competition occurs between a biotinylated and a non-
biotinylated antigen for a fixed number of antibody binding sites on the highly specific 
polyclonal Kennaway G280 anti-melatonin antibody. The amount of bound biotinylated antigen, 
which is inversely proportional to the concentration of melatonin in the sample, is determined by 
use of an enzyme marker (streptavidin conjugated to horseradish peroxidase) and a chromogenic 
substrate (tetramethylbenzidine) that results in a colour change from blue to yellow once an 
acidic stop solution is added. The optical density of the solution can then be read with a 
spectrophotometer at 450nm and quantification of the unknowns can be determined by 
comparing the enzymatic activity of the unknowns against a standard curve. The analytical 
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sensitivity (limit of detection) of the ELISA kits for melatonin in saliva was 0.3pg/mL. For this 
study, each saliva sample was run in duplicate in order to minimize experimental error. The 
optical densities of the samples were read using a Thermo Scientific Multiskan Spectrum 
spectrophotometer (Thermo Fisher Scientific Inc., Waltham, MA, USA). All procedures were 
conducted as per IBL International’s Non-Extraction Melatonin Saliva ELISA Instructions for 
Use manual and no changes were made to this protocol. The resulting data were plotted in 
MATLAB version 7.10 (Natick, MA, USA) and a cosinor analysis was carried out (Lerchl and 
Partsch, 1994), whereby the sum of squares equation was used to fit a sinusoidal curve to the 
data points by squaring and summing the distances between each point to find the smallest sum 
of squares value. 
 
 
2.5 Scanning Procedures 
 
Participants were each scanned using magnetic resonance imaging (MRI) on two 
occasions: once after the baseline period and once immediately after the experimental period. 
The baseline scans occurred within one week of participants providing their saliva samples for 
the baseline period; the experimental scans occurred on the last of the eight days that participants 
provided their saliva samples for the experimental period. All scanning sessions occurred within 
within one to two weeks of administering the last emotional Stroop test. Each scanning session 
was 20 minutes in length and involved three components: an anatomical scan (6 minutes), a 
resting-state scan (8 minutes) and a DTI scan (4.5 minutes). All imaging was performed using a 
3-Tesla Siemens Tim Trio whole body MRI scanner equipped with a 32-channel head coil, 
located in the Sherman Health Sciences Building of the Center for Vision Research at York 
University. Participants lay supine in the scanner with earplugs and cushions around their heads 
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so as to reduce both acoustic noise and head motion. Participants were instructed to close their 
eyes and let their mind wander for the resting state scan, while for the anatomical and DTI scans 
participants had the option to keep their eyes open or closed. 
T1-weighted anatomical images were acquired with the following parameters: spin echo, 
matrix = 256 x 256 pixels, voxel size = 1mm3, TR = 1900ms, TE = 2.52ms, flip angle = 9°. T2*-
weighted images were acquired with the following parameters: GRAPPA echo planar imaging 
with an acceleration factor of 2x, slices = 32, matrix = 56 x 70 pixels, FOV = 210mm x 168mm, 
voxel size = 3mm x 3mm x 4mm, TR = 2000ms, TE = 30ms, flip angle = 90°. Diffusion-
weighted images were acquired with the following parameters: slices = 60, base resolution = 122 
x 122 pixels, reconstructed matrix = 976 x 976 pixels, FOV = 240mm, voxel size = 1.97mm x 
1.97mm x 2mm, TR = 8300ms, TE = 100ms, flip angle = 90°, slice thickness = 2mm, inter-slice 
interval = 138ms, gradient directions = 30, b value = 1000s/mm2. 
 
 
2.6 Data Analysis 
 
2.6.1 DTI Pre-processing 
 
From the scans, DTI data were chosen to be analyzed as this technique is highly sensitive 
to changes in the brain (Jones et al., 2012). All DTI data analyses were performed using FSL 
version 4.1.9 (Analysis Group, FMRIB Software Library, Oxford, UK). Prior to preprocessing, 
all raw DTI and T1 series images were converted from DICOM to 4D NIfTI nii files using the 
dcm2nii program (developer Chris Rorden, South Carolina, USA) to ensure compatibility with 
the FSL software. Once converted, the Eddy Current Correction option in the FDT Diffusion 
Toolbox version 2.0 was used to perform motion correction, correcting for any movement and 
distortions that may have occurred during the scanning session. The BET Brain Extraction 
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Toolbox version 2.1 was then used to generate skull-stripped images for each subject. The 
fractional intensity threshold was lowered from the default of 0.5 to 0.3 in order to prevent parts 
of the cortex being removed with the skull during the process of brain extraction. Once complete, 
the diffusion tensor model was fitted to the data using the DTIFIT Reconstruct Diffusion Tensors 
option in the FDT Diffusion Toolbox. This step fit a diffusion tensor model at each voxel, 
generating eigenvector, eigenvalue, fractional anisotropy (FA) and mean diffusivity (MD) maps. 
Following DTIFIT, a Bayesian Estimation of Diffusion Parameters Obtained Using Sampling 
Techniques (BEDPOST) analysis was conducted using the BEDPOSTX Estimation of Diffusion 
Parameters option in the FDT Diffusion Toolbox. This analysis yielded files necessary to carry 
out probabilistic tractography once registration was complete. Registration allows tractography 
results to be stored in spaces other than diffusion space, and was carried out using the Linear 
Image Registration Tool within the FDT Diffusion Toolbox. The files resulting from registration 
are transformation matrices between diffusion, structural and standard space, with the 
transformation matrices between diffusion and structural space being derived using 6 degrees of 
freedom and the transformation matrices between structural and standard space being derived 
using 12 degrees of freedom. 
 
2.6.2 Tract-Based Spatial Statistics and Voxelwise Statistics 
 
Tract-based spatial statistics (TBSS) were run using FSL version 4.1.9 (Analysis Group, 
FMRIB Software Library, Oxford, UK). TBSS is commonly conducted through use of FA 
images in voxelwise statistical analyses. In this study, TBSS was run in order to localize changes 
in the brain related to performing and learning an attentional task while undergoing internal 
desynchronization. First, all subjects’ FA images were eroded slightly and the end slices zeroed 
to remove likely outliers from the diffusion tensor fitting. Non-linear registration (one 
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registration per subject) was then run in order to align all subjects’ FA images using a 1mm3 
FMRIB58_FA standard space image as the target. Following registration, each subject’s FA 
image was non-linearly transformed to the target and affine-aligned to bring them into the 
1x1x1mm MNI152 standard space, which resulted in the transformation of each subject’s 
original FA images into standard-space versions. These standard-space FA images were then 
merged into a single 4D image file and the mean of all FA images created, with this mean then 
being skeletonised. The mean FA skeleton image was then thresholded at a value of 0.2, which 
produced a binary skeleton mask that defines the set of voxels used in subsequent analyses. 
Lastly, all subjects’ aligned FA data were projected onto the mean FA skeleton, which resulted 
in a single 4D image file containing the projected skeletonised FA data. 
Voxelwise statistics were run using the projected skeletonized 4D image file to determine 
which FA skeleton voxels were significantly different between the two groups of subjects. The 
randomize tool was used to run the statistics, with the design matrix set up as a t-test for a simple 
two-group comparison (baseline vs. experimental condition). In addition to the randomize tool, 
the threshold-free cluster enhancement (TFCE) option was used for robust cluster-based 
thresholding. This statistical test resulted in two TFCE p-value contrast image files that are fully 
corrected for multiple comparisons across space (contrast 1: baseline > experimental; contrast 2: 
experimental > baseline), with a threshold of 0.95 giving rise to significant clusters of FA voxels 
in each of the contrasts. From these contrast image files, whole brain and ROI specific FA values 
from the IFG were extracted for raw data comparison between the baseline and experimental two 
conditions. 
The entirety of this procedure was repeated to determine significant differences in MD 
voxels in each of the contrasts. Similar to TBSS with the FA data, the original nonlinear 
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registration was applied to the MD data and all subjects’ warped MD data were merged into a 
single 4D image file. This 4D image file was then projected onto the original mean FA skeleton, 
as the original FA data were used to find the projection vectors for the MD data. This resulted in 
a 4D projected MD data file on which the voxelwise statistics were run (in the same manner as 
described above). From these contrast image files, whole brain and ROI specific MD values from 
the IFG were extracted for raw data comparison between the two conditions. 
 
2.6.3 Tractography 
 
Probabilistic tractography was carried out using the PROBTRACKX Probabilistic 
Tracking option in the FDT Diffusion Toolbox of FSL. Prior to running tractography, two single 
masks of the left and right hippocampi, the seed ROIs, were made in FSLView version 3.1.8, 
defining the voxels from which streamline quantification (tractography) would emanate. This 
was done by locating the desired structure on the Juelich Histological Atlas and creating a binary 
mask on the T1 image of the Montreal National Institute’s MNI152 1mm standard brain. Once 
complete, the mask image was loaded into FDT and the previously calculated standard to 
diffusion transformation matrix was defined, as the seed image was created in standard and not 
diffusion space. A single waypoint mask of the inferior frontal gyrus (IFG) with both the left and 
right hemispheres defined was used as an inclusion mask – that is, tracts that did not pass 
through this mask were discarded from the calculation of the connectivity distribution. The IFG 
was chosen as an ROI for this study as fMRI results previously published by Ovaysikia et al. 
(2012) demonstrated strong bilateral activation of this area when participants performed the 
emotional Stroop task. The number of samples (or the number of individual pathways that are 
drawn through the probability distributions on the principle fibre direction) was set to 5000, and 
the curvature threshold (or the limit of how sharply pathways can turn as an exclusion criteria for 
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implausible pathways) was set to 0.2 (corresponding to a minimum angle of approximately 80°). 
The Loopcheck option was also selected, which allowed the program to terminate pathways that 
traveled to a point where they have already been. The step length was set to 0.5mm and the 
maximum number of steps was set to 2000, which together, corresponds to a distance of 1m 
(after which samples are terminated). This tractography procedure resulted in an image of the 
connectivity distribution summed from all the voxels in the seed ROI and passing through the 
defined waypoint masks.  
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3. Results 
3.1 Behavioural Results 
 
3.1.1 Validation of Emotional Stroop Paradigm 
 
The current emotional Stroop task was first used by Ovaysikia et al. (2011), who 
demonstrated that participants had a significantly higher mean RT and a significantly greater 
amount of errors when instructed to respond to the facial emotion compared to the written word. 
In an attempt to validate this paradigm for our purposes, the four baseline runs of each 
instruction set were averaged for all 10 participants of the current experiment to determine 
whether the same trends would be found. A paired samples Student’s t-test was performed on the 
RTs of the face and word instruction sets, as well as on the number of errors in the face and word 
instruction sets (Table 1 in Appendix F). Indeed, it was found that participants had a significantly 
higher mean RT (t(9) = 10.492, p < 0.001) and a significantly greater amount of errors (t(9) = 
4.675, p < 0.001) when instructed to respond to the facial emotion compared to the written word 
(Figure 4).  
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Figure 4. Overall mean reaction times (RTs; grey bars) and errors (white bars) from ten subjects 
performing the emotional Stroop task during the baseline period. Congruent and incongruent trials have 
been collapsed within each instruction set to validate the emotional Stroop test by showing that the 
current data corroborate those published by Ovaysikia et al. (2011). The error bars signify the standard 
error of the mean (SEM). There was a statistically significant difference between the face and word 
instruction sets for both the RTs (p < 0.001) and errors (p < 0.001). 
 
Further breaking down each instruction set into its component congruent and incongruent 
trials revealed an expected Stroop effect, whereby the incongruent trials resulted in longer RTs 
and more errors, regardless of instruction. Results from a paired samples Student’s t-test 
performed on the RTs of the congruent and incongruent trials for the face instruction (Table 2 in 
Appendix F) demonstrated a significantly higher mean RT for the incongruent trials (t(9) = 4.783, 
p < 0.001; Figure 5) compared to the congruent trials. Similarly, results from a paired samples 
Student’s t-test performed on the RTs of the congruent and incongruent trials for the word 
instruction (Table 2 in Appendix F) demonstrated a significantly higher mean RT for the 
incongruent trials (t(9) = 2.357, p < 0.05; Figure 5) compared to the congruent trials. Moreover, 
results from a paired samples Student’s t-test performed on the total number of errors of the 
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congruent and incongruent trials for the face instruction (Table 2 in Appendix F) demonstrated a 
significantly greater amount of errors for the incongruent trials (t(9) = 5.325, p < 0.001; Figure 5) 
compared to the congruent trials. Lastly, results from a paired samples Student’s t-test performed 
on the total number of errors of the congruent and incongruent trials for the word instruction 
(Table 2 in Appendix F) also demonstrated a significantly greater amount of errors for the 
incongruent trials (t(9) = 5.075, p < 0.001; Figure 5) compared to the congruent trials. Overall, the 
incongruent trials of the face instruction set resulted in the longest RTs and the greatest amount 
of errors, followed by the congruent trials of the face instruction set, the incongruent trials of the 
word instruction set, and the congruent trials of the word instruction set, which produced the 
shortest RTs and the least amount of errors.  
Figure 5. Overall mean reaction times (RTs; grey bars) and errors (white bars) from ten subjects 
performing the emotional Stroop task during the baseline period. The error bars signify the standard error 
of the mean (SEM). A Stroop effect is demonstrated, with significantly longer RTs for the incongruent 
trials in both the face (p < 0.001) and word (p < 0.05) instruction sets, as well as significantly more errors 
for the incongruent trials in both the face (p < 0.001) and word (p < 0.001) instruction sets.  
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3.1.2 Behavioural Measures: Sleep Times 
 
To assess the effect of the melatonin treatment on sleep, participants’ logs of their daily 
sleep times during both baseline and experimental periods were analyzed. Participants’ sleep 
times were normalized to time of dim-light melatonin onset (DLMO = time 0), and a paired 
samples Student’s t-test was performed (Table 3 in Appendix F). There was a significant 
difference between baseline and experimental sleep times for all participants’ pooled sleep data 
(t(9) = 2.945, p < 0.05), with a leftward-shifted mean and a lower amplitude of distribution during 
the experimental period (Figure 6).  
Figure 6. Histogram of ten subjects’ baseline (top panel) and experimental (bottom panel) sleep times. 
Numbers on the x-axis represent times relative to dim-light melatonin onset (DLMO = time 0); numbers 
on the y-axis represent frequency (i.e. the number of occurrences). All ten subjects took part in the 
melatonin treatment. There was a statistically significant difference between the baseline and 
experimental sleep times (p < 0.05). 
 
Further breaking down the data into the individual baseline and experimental days 
demonstrated a strong effect of the melatonin treatment on participants’ sleep times. 
Administering the melatonin treatment in the afternoon on days 1, 2, 5, and 6 of the experimental 
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period resulted in an overall shift towards earlier than average sleep times, while administering 
the melatonin treatment in the morning on days 3, 4, 7, and 8 of the experimental period resulted 
in an overall shift towards later than average sleep times (Figure 7). Paired samples Student’s t-
tests indicated significant differences between day 1 of melatonin treatment and all days 
preceding it (p < 0.05 for all comparisons) as well as between day 1 and day 4 of melatonin 
treatment (p < 0.005), indicating that the melatonin treatment worked as expected. Of interest to 
note is that day 1 of the experimental period demonstrated the largest effect of melatonin on 
sleep, as all participants’ sleep times shifted to an earlier than average time (Figure 7). No 
significant difference in variability between baseline and experimental sleep times was found (p 
> 0.1), though a trend of increasing variability was demonstrated over the course of the eight day 
experimental period (insets in Figure 7 and Figure 8).!!
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Figure 7. Individual baseline and experimental sleep data from all ten subjects. The first 8 groupings on the x-axis represent the 8 baseline days, 
while the last 8 groupings represent the 8 experimental days. Numbers on the y-axis represent sleep times relative to dim-light melatonin onset 
(DLMO = 0). The x-axis crosses at time 2.5 on the y-axis, which is the average sleep time. Bars below the x-axis represent sleep times occurring 
before average; bars above the x-axis represent sleep times occurring after average. Coloured bars represent each individual subjects’ sleep times 
on that specific day; black bars represent exogenous melatonin administered to participants during the eight days of the experimental period. 
Graphical insets show a trend of decreasing variability in sleep times during the baseline period and a trend of increasing variability in sleep times 
during the experimental period, though no statistically significant difference was found (p > 0.1). 
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Figure 8. Example of Subject 6’s sleep data. Numbers on the x-axis represent the 8 baseline and 8 
experimental days; numbers on the y-axis represent times relative to dim-light melatonin onset (DLMO = 
time 0). Dark grey squares represent baseline sleep times; light grey squares represent experimental sleep 
times. Graphical inset shows an increase in variability between baseline and experimental sleep times. 
 
 
3.1.3 Behavioural Measures: Wake Times 
 
To assess the effect of the melatonin treatment on waking, participants’ logs of their daily 
wake times during both baseline and experimental periods were analyzed. Similar to the analysis 
of sleep times, participants’ wake times were normalized to time of dim-light melatonin onset 
(DLMO = time 0), and a paired samples Student’s t-test was performed (Table 4 in Appendix F). 
There was no significant difference between baseline and experimental wake times as 
demonstrated by the resulting two-tailed p value (t(9) = 1.788, p > 0.05). However, as an estimate 
of directionality was previously hypothesized, a one-tailed p value was chosen in favour of the 
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two-tailed p value to indicate significance. As such, the results demonstrate a significant 
difference between baseline and experimental wake times (t(9) = 1.788, p < 0.05), with a slightly 
leftward-shifted mean and a slightly lower amplitude of distribution during the experimental 
period (Figure 9).  
 
Figure 9. Histogram of ten subjects’ baseline (top panel) and experimental (bottom panel) wake times. 
Numbers on the x-axis represent times relative to dim-light melatonin onset (DLMO = time 0); numbers 
on the y-axis represent frequency (i.e. the number of occurrences). All ten subjects took part in the 
melatonin treatment. There was a statistically significant difference between the baseline and 
experimental wake times (p < 0.05, one-tailed t-test). 
 
Further breaking down the data into the individual baseline and experimental days also 
demonstrated an effect of the melatonin treatment on participants’ wake times. Administering the 
melatonin treatment in the afternoon on days 1, 2, 5, and 6 of the experimental period resulted in 
an overall shift towards earlier than average wake times, while administering the melatonin 
treatment in the morning on days 3, 4, 7, and 8 of the experimental period resulted in an overall 
shift towards later than average wake times (Figure 10). Of interest to note is that days 1 and 8 of 
the experimental period shifted all but one participants’ wake times in the same direction (Figure 
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10). No significant difference in variability between baseline and experimental sleep times was 
found (p > 0.5), though a slight trend of increasing variability was demonstrated over the course 
of the eight day experimental period (insets in Figure 10 and Figure 11). 
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Figure 10. Individual baseline and experimental wake data from all ten subjects. The first 8 groupings on the x-axis represent the 8 baseline days, 
while the last 8 groupings represent the 8 experimental days. Numbers on the y-axis represent wake times relative to dim-light melatonin onset 
(DLMO = 0). The x-axis crosses at time 10.5 on the y-axis, which is the average wake time. Bars above the x-axis represent wake times occurring 
before average; bars above the x-axis represent wake times occurring after average. Coloured bars represent each individual subjects’ wake times 
on that specific day; black bars represent exogenous melatonin administered to participants during the eight days of the experimental period. 
Graphical insets show almost no change in variability in wake times during the baseline period and a slight trend of increasing variability in wake 
times during the experimental period, though no statistically significant difference was found (p > 0.5). 
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Figure 11. Example of Subject 10’s wake data. Numbers on the x-axis represent the 8 baseline and 8 
experimental days; numbers on the y-axis represent times relative to dim-light melatonin onset (DLMO = 
time 0). Dark grey squares represent baseline wake times; light grey squares represent experimental wake 
times. Graphical inset shows an increase in variability between baseline and experimental wake! times. 
Note that the baseline and experimental data points for days 2 and 5 overlap. 
 
 
3.1.4 Behavioural Measures: Sleep Quality Ratings 
 
To assess the effect of the melatonin treatment on sleep quality, participants’ logs of their 
daily sleep quality ratings during both baseline and experimental periods were analyzed. Two 
participants did not report their sleep quality ratings and were thus left out of the analysis. The 
third participant’s sleep quality ratings were determined to be outliers as they did not fit the 
consistent trend exhibited by the remaining participants, and the data were thus excluded from 
the analysis. The exclusion of these three participants resulted in a sample size of seven for each 
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of the baseline and experimental periods; thus a linear mixed models test was used for the 
analysis (Table 5 in Appendix F). A significant difference between baseline and experimental 
sleep quality ratings was found (t(6) = 3.007, p < 0.005; Figure 12).  On average, participants 
reported a poorer quality of sleep during the experimental period than the baseline period, with 
more ratings of 2 (poor sleep), 3 (average sleep) and 4 (good sleep) than 5 (excellent sleep). 
 
 
Figure 12. Histogram of seven subjects’ baseline (top panel) and experimental (bottom panel) quality of 
sleep ratings. Two of the remaining three subjects did not report their sleep quality ratings throughout the 
experiment and one subject’s ratings were determined to be outliers, thus these participants were excluded 
from the analysis. Numbers on the x-axis represent subjects’ self-reported quality of sleep (1 = very poor; 
2 = poor, 3 = average; 4 = good; 5 = excellent); numbers on the y-axis represent frequency (i.e. the 
number of occurrences). All seven subjects took part in the melatonin treatment. There was a statistically 
significant difference between the baseline and experimental quality of sleep ratings (p < 0.005). 
 
 
3.1.5 Emotional Stroop Task 
 
During the eight-day experimental period, participants were tested on the emotional 
Stroop task four times. Participants’ performance on this task was used as a measure of cognitive 
ability while undergoing the melatonin treatment. Paired samples Student’s t-tests revealed a 
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Stroop effect in three of the four conditions (Table 6 in Appendix F), with the incongruent trials 
resulting in significantly higher mean RTs in the face instruction (t(9) = 4.973, p < 0.001) and 
significantly more errors in both the face (t(9) = 5.075, p < 0.001) and word (t(9) = 8.187, p < 
0.001) instructions (Figure 13). There was no significant difference in RTs between the 
congruent and incongruent trials for the word instruction (t(9) = 0.880, p > 0.1; Figure 13). 
Figure 13. Overall mean reaction times (RTs; grey bars) and errors (white bars) from ten subjects 
performing the emotional Stroop task during the experimental period. The error bars signify the standard 
error of the mean (SEM). A Stroop effect is seen in three of the four conditions, with significantly longer 
RTs for the incongruent trials in the face (p < 0.001) but not the word (p > 0.1) instruction set, and 
significantly more errors for the incongruent trials in both the face (p < 0.001) and word (p < 0.001) 
instruction sets. 
 
In order to delineate further trends in the data, congruent and incongruent baseline and 
experimental trials for each instruction set were compared by use of paired samples Student’s t-
tests (Table 7 in Appendix F). These analyses revealed that participants responded significantly 
faster in the experimental period for the congruent trials of the face instruction (t(9) = 2.424, p < 
0.05) as well as for the incongruent trials of the word instruction (t(9) = 3.132, p < 0.01), but not 
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for the incongruent trials of the face instruction (t(9) = 2.046, p > 0.05) nor for the congruent trials 
of the word instruction (t(9) = 2.192, p > 0.05; Figure 14). It was also found that participants 
made significantly fewer errors in the experimental period for the congruent trials (t(9) = 2.216, p 
< 0.05) but not for the incongruent trials (t(9) = 1.135, p > 0.1) of the face instruction (Figure 14). 
Conversely, participants made significantly more errors in the experimental period for the 
incongruent trials of the word instruction (t(9) = 2.173, p < 0.05), but did not make significantly 
more or fewer errors for the congruent trials of the same instruction (t(9) = 0.142, p > 0.1; Figure 
14).  
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Figure 14. Overall mean reaction times (RTs; grey bars) and errors (white bars) from ten subjects 
performing the emotional Stroop task. All ten subjects took part in the melatonin treatment, and their 
baseline and experimental period performances are shown for each instruction set (face and word). The 
instruction sets are further broken down into their component congruent and incongruent trials. The error 
bars signify the standard error of the mean (SEM). There was a statistically significant difference between 
the baseline and experimental periods for RTs in the congruent trials of the face instruction set (p < 0.05), 
as well as for RTs in the incongruent trials of the word instruction set (p < 0.01). There was no 
statistically significant difference between the baseline and experimental periods for RTs in the 
incongruent trials of the face instruction set (p > 0.05), nor for RTs in the congruent trials of the word 
instruction set (p > 0.05). A similar trend is seen for the errors, with the congruent trials of the face 
instruction set and the incongruent trials of the word instruction set reaching statistical significance 
between the baseline and experimental periods (p < 0.05 for both), but the errors in the incongruent trials 
of the face instruction set and the congruent trials of the word instruction set not reaching significance (p 
> 0.1 for both).  
 
To determine whether there were interactions between the baseline and experimental 
periods, the congruent and incongruent trials, and the face and word instructions, a 3-way 
repeated measures ANOVA was performed for both the RTs and errors. Three within-subject 
factors with two levels each were used: period (baseline, experimental), congruency (congruent, 
incongruent), and instruction (face, word). Results from the first repeated measures ANOVA 
demonstrated a significant main effect of period on RTs (F(1,9) = 7.406, p < 0.05), a significant 
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main effect of congruency on RTs (F(1,9) = 31.835, p < 0.001), and a significant main effect of 
instruction on RTs (F(1,9) = 121.543, p < 0.001) – that is, the baseline and experimental periods, 
the congruent and incongruent conditions, and the face and word instructions all had significant 
effects on RTs. There was also a significant interaction found between the factors of congruency 
and instruction on RTs (F(1,9) = 20.509, p < 0.01), as well as between the factors of period, 
congruency, and instruction on RTs (F(1,9) = 5.063, p < 0.05; see Table 8 in Appendix F). The 
interactions between the factors of period and congruency and the factors of period and 
instruction on RTs did not reach significance (F(1,9) =1.206, p > 0.1 and F(1,9) = 0.005, p > 0.5, 
respectively). Results from the second repeated measures ANOVA demonstrated a significant 
main effect of congruency on errors (F(1,9) =38.881, p < 0.001) and a significant main effect of 
instruction on errors (F(1,9) =22.613, p < 0.001; Table 9 in Appendix F) – that is, the congruent 
and incongruent conditions and the face and word instructions all had significant effects on the 
error rates. The main effect of period on errors did not reach significance (F(1,9) =0.999, p > 0.1). 
There was also a significant interaction found between the factors of congruency and instruction 
on errors (F(1,9) =19.253, p < 0.005; Table 9 in Appendix F). The interactions between the factors 
of period and congruency, the factors of period and instruction, and the factors of period, 
congruency and instruction on errors did not reach significance (F(1,9) = 0.150, p > 0.5, F(1,9) = 
3.929, p > 0.05, and F(1,9) = 1.255, p > 0.1, respectively; Table 9 in Appendix F). 
 
 
3.2 Diffusion Tensor Imaging 
 
3.2.1 Tract-Based Spatial Statistics and Voxelwise Statistics 
 
To determine changes in white matter microstructure in the brain as a function of the 
melatonin treatment, TBSS and voxelwise statistics were performed on all participants’ baseline 
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and experimental period DTI data. These analyses yielded voxels of significance at a 95% 
confidence interval in the left and right IFG for both FA and MD maps. FA values within the 
whole brain (Figures 15 and 16; t(9) = 9.528, p < 0.001) as well as within the left IFG (Figures 
17, 18 and 19; t(9) = 5.223, p < 0.001) and right IFG (Figures 20, 21 and 22; t(9) = 2.993, p < 
0.01) decreased significantly in the experimental scan compared to the baseline scan (Table 10 in 
Appendix F).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Whole brain FA values from ten participants’ baseline and experimental scans. FA values 
range from 0 to 1. The black bars represent FA values from participants’ baseline scan; white bars 
represent FA values from participants’ experimental scan. Decreases in FA values from the baseline to 
experimental scans can be seen. 
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Figure 16. Whole brain FA means from ten participants’ baseline and experimental scans. Participant 
data have been averaged within each scanning period to demonstrate the significant decrease in FA values 
during the experimental scan (p < 0.001). The error bars signify the standard error of the mean (SEM). 
 
  
Figure 17. FA values from the left IFG from ten participants’ baseline and experimental scans. FA values 
range from 0 to 1. The black bars represent FA values within the left IFG from participants’ baseline 
scan; white bars represent FA values within the left IFG from participants’ experimental scan. Decreases 
in FA values from the baseline to experimental scans can be seen. 
 
0.49 
0.5 
0.51 
0.52 
0.53 
0.54 
0.55 
0.56 
0.57 
0.58 
BASELINE SCAN EXPERIMENTAL SCAN 
FA
 V
al
ue
 
Whole Brain FA Means 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
FA
 V
al
ue
 
Subjects 
Left IFG FA Values 
BASELINE SCAN 
EXPERIMENTAL 
SCAN 
! 63 
 
Figure 18. FA means from the left IFG from ten participants’ baseline and experimental scans. 
Participant data have been averaged within each scanning period to demonstrate the significant decrease 
in FA values within the left IFG during the experimental scan (p < 0.001). The error bars signify the 
standard error of the mean (SEM). 
 
 
Figure 19. Tract-based spatial statistics (TBSS) images from ten subjects’ fractional anisotropy (FA) data 
for the experimental > baseline contrast. All three brain images are presented in radiological convention. 
Voxelwise statistics were run on the 4D skeletonised FA image created during TBSS pre-processing. The 
green tracts represent the mean skeletonized FA data, while the red tracts represent voxels that resulted in 
significantly different FA values at a confidence interval of 95%. The left and right IFG are highlighted, 
and the blue circles represent significant voxels within the left IFG that were used for analysis. MNI 
coordinates used: x = -41, y = 3, z = 20. 
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Figure 20. FA values from the right IFG from ten participants’ baseline and experimental scans. FA 
values range from 0 to 1. The black bars represent FA values within the right IFG from participants’ 
baseline scan; white bars represent FA values within the right IFG from participants’ experimental scan. 
Decreases in FA values from the baseline to experimental scans can be seen. 
 
 
 
Figure 21. FA means from the right IFG from ten participants’ baseline and experimental scans. 
Participant data have been averaged within each scanning period to demonstrate the significant decrease 
in FA values within the right IFG during the experimental scan (p < 0.01). The error bars signify the 
standard error of the mean (SEM). 
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Figure 22. Tract-based spatial statistics (TBSS) images from ten subjects’ fractional anisotropy (FA) data 
for the experimental > baseline contrast. All three brain slices are presented in radiological convention. 
Voxelwise statistics were run on the 4D skeletonised FA image created during TBSS pre-processing. The 
green tracts represent the mean skeletonized FA data, while the red tracts represent voxels that resulted in 
significantly different FA values at a confidence interval of 95%. The left and right IFG are highlighted, 
and the blue circles represent significant voxels within the right IFG that were used for analysis. MNI 
coordinates used: x = 50, y = 1, z = 20. 
 
 
 
Conversely, MD values within the whole brain (Figures 23 and 24; t(9) = 8.082, p < 0.001) 
as well as within the left (Figures 25, 26 and 27; t(9) = 2.254, p < 0.05) and right IFG (Figures 28, 
29 and 30; t(9) = 3.665, p < 0.005) increased significantly in the experimental scan compared to 
the baseline scan (Table 11 in Appendix F). As with the FA values, the right IFG demonstrated a 
greater increase in MD values than the left IFG, though the change in MD values in both 
hemispheres did reach significance. TBSS and voxelwise statistics did not yield any voxels of 
significance at a 95% confidence interval in the left or right hippocampus.  
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Figure 23. Whole brain MD values from ten participants’ baseline and experimental scans. MD values 
have physical unites of m2/s. The black bars represent MD values from participants’ baseline scan; white 
bars represent MD values from participants’ experimental scan. Increases in MD values from the baseline 
to experimental scans can be seen.   
 
 
 
Figure 24. Whole brain MD means from ten participants’ baseline and experimental scans. Participant 
data have been averaged within each scanning period to demonstrate the significant increase in MD 
values during the experimental scan (p < 0.001). The error bars signify the standard error of the mean 
(SEM). 
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Figure 25. MD values from the left IFG from ten participants’ baseline and experimental scans. MD 
values have physical units of m2/s. The black bars represent MD values within the left IFG from 
participants’ baseline scan; white bars represent MD values within the left IFG from participants’ 
experimental scan. Increases in MD values from the baseline to experimental scans can be seen. 
 
 
 
Figure 26. MD means from the left IFG from ten participants’ baseline and experimental scans. 
Participant data have been averaged within each scanning period to demonstrate the significant increase in 
MD values within the left IFG during the experimental scan (p < 0.05). The error bars signify the standard 
error of the mean (SEM). 
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Figure 27. Tract-based spatial statistics (TBSS) images from ten subjects’ mean diffusivity (MD) data for 
the baseline > experimental contrast. All three brain images are presented in radiological convention. 
Voxelwise statistics were run on the 4D skeletonised FA image created during TBSS pre-processing. The 
green tracts represent the mean skeletonized FA data, while the red tracts represent voxels that resulted in 
significantly different MD values at a confidence interval of 95%. The left and right IFG are highlighted, 
and the blue circles represent significant voxels within the left IFG that were used for analysis. MNI 
coordinates used: x = -40, y = 19, z = 16. 
 
 
Figure 28. MD values from the right IFG from ten participants’ baseline and experimental scans. MD 
values have physical units of m2/s. The black bars represent MD values within the right IFG from 
participants’ baseline scan; white bars represent MD values within the right IFG from participants’ 
experimental scan. Increases in MD values from the baseline to experimental scans can be seen. 
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Figure 29. MD means from the right IFG from ten participants’ baseline and experimental scans. 
Participant data have been averaged within each scanning period to demonstrate the significant increase in 
MD values within the right IFG during the experimental scan (p < 0.005). The error bars signify the 
standard error of the mean (SEM). 
 
 
 
Figure 30. Tract-based spatial statistics (TBSS) images from ten subjects’ mean diffusivity (MD) data for 
the baseline > experimental contrast. All three brain slices are presented in radiological convention. 
Voxelwise statistics were run on the 4D skeletonised FA image created during TBSS pre-processing. The 
green tracts represent the mean skeletonized FA data, while the red tracts represent voxels that resulted in 
significantly different MD values at a confidence interval of 95%. The left and right IFG are highlighted, 
and the blue circles represent significant voxels within the right IFG that were used for analysis. MNI 
coordinates used: x = 41, y = 12, z = 20. 
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3.2.2 Tractography 
 
To assess changes in white matter pathways underlying areas of higher cognitive 
function, probabilistic tractography was carried out using the left and right hippocampal 
entorhinal cortex (HEC) as seed regions and the left and right IFG as target regions. Paired 
samples t-tests were performed on the baseline and experimental SC values from each 
hemisphere independently (Table 12 in Appendix F), and no significant differences between 
baseline and experimental scans were found in either the left (Figures 31 and 32; t(9) = 0.733, p > 
0.1) or right (Figures 31 and 33; t(9) = 0.330, p > 0.1) hemisphere. Furthermore, no consistent 
trends in SC values were found within or between participants (Figure 34). 
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Figure 31. SC means from ten participants’ baseline and experimental scans. Participant data have been 
averaged within each scanning period and seed region hemisphere to demonstrate that no significant 
changes in SC values were found (p > 0.1). The black bars represent SC values from the baseline scan 
with streamlines originating from the left HEC and terminating at the left and right IFG; the horizontal 
striped bars represent SC values from the experimental scan with streamlines originating from the left 
HEC and terminating at the left and right IFG; the white bars represent SC values from the baseline scan 
with streamlines originating from the right HEC and terminating at the left and right IFG; the diagonal 
striped bars represent SC values from the experimental scan with streamlines originating from the right 
HEC and terminating at the left and right IFG. The error bars signify the standard error of the mean 
(SEM). 
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Figure 32. Probabilistic streamlines (brown) are shown from one subject, originating from the left HEC 
(red and yellow areas at the bottom of the sagittal and coronal slices) and terminating at the left and right 
IFG (red and orange areas at the top of the sagittal and transverse slices). All three brain slices are 
presented in radiological convention.  
 
 
 
Figure 33. Probabilistic streamlines (brown) are shown from one subject, originating from the right HEC 
(red and orange areas at the bottom of the sagittal and coronal slices) and terminating at the left and right 
IFG (red and orange areas at the top of the sagittal, coronal and transverse slices). All three brain slices 
are presented in radiological convention. 
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Figure 34. SC values from ten participants’ baseline and experimental scans. The black bars represent SC 
values from the baseline scan with streamlines originating from the left HEC and terminating at the left 
and right IFG; the horizontal striped bars represent SC values from the experimental scan with 
streamlines originating from the left HEC and terminating at the left and right IFG; the white bars 
represent SC values from the baseline scan with streamlines originating from the right HEC and 
terminating at the left and right IFG; the diagonal striped bars represent SC values from the experimental 
scan with streamlines originating from the right HEC and terminating at the left and right IFG. No 
consistent trends in the data were found. 
 
 
3.3 Correlations 
 
To determine whether there were any relationships between the brain and behavioural 
measures, correlation analyses were performed. Subtraction values (i.e. experimental value 
minus baseline value) of the significant results were computed to plot the correlation graphs, and 
a linear line of best fit was added to data. It was found that congruent face errors significantly 
correlated with right IFG FA values (Table 13 in Appendix F; Pearson’s R Correlation = 0.822, p 
< 0.005; Figure 35), congruent face errors significantly correlated with right IFG MD values 
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(Table 14 in Appendix F; Pearson’s R Correlation = 0.684, p < 0.05; Figure 36), and incongruent 
word errors significantly correlated with left IFG FA values (Table 15 in Appendix F; Pearson’s 
R Correlation = -0.743, p < 0.01; Figure 37).  
Figure 35. Graph correlating congruent face errors and right IFG FA values. Numbers on the x-axis 
represent congruent face error subtraction values; numbers on the y-axis represent right IFG FA 
subtraction values. Each square represents one participant. A significant positive correlation was found (p 
< 0.005), with decreases in congruent face errors correlated with decreases in right IFG FA values. 
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Figure 36. Graph correlating congruent face errors and right IFG MD values. Numbers on the x-axis 
represent congruent face error subtraction values; numbers on the y-axis represent right IFG MD 
subtraction values. Each square represents one participant. A significant positive correlation was found (p 
< 0.05), with decreases in congruent face errors correlated with decreases in right IFG MD values. 
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Figure 37. Graph correlating incongruent word errors and left IFG FA values. Numbers on the x-axis 
represent incongruent word error subtraction values; numbers on the y-axis represent left IFG FA 
subtraction values. Each square represents one participant. A significant negative correlation was found (p 
< 0.01), with increases in incongruent word errors correlated with decreases in left IFG FA values. 
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4. Discussion 
4.1 Validation of the Emotional Stroop Test as a Cognitive Measure 
 
The present study used an affective face/word emotional Stroop task to measure 
participants’ cognitive performance. As expected, it was found that the incongruent trials 
produced significantly greater RTs and significantly more errors compared to the congruent 
trials, regardless of the instruction given. This Stroop effect has been well documented in the 
literature since the conception of the Stroop task in 1935, and has been demonstrated on 
numerous occasions by researchers using the Stroop task and the emotional Stroop task alike 
(Raccuglia and Phaf, 1997; Etkin et al., 2006; Preston and Stansfield, 2008). It was also found 
that participants responded significantly faster and made significantly fewer errors when 
instructed to respond to the written word compared to the facial emotion. In contrast to this 
finding, Beall and Herbert (2008) demonstrated larger interference effects for words than faces in 
their emotional Stroop task, suggesting a more automatic processing for affective faces 
compared to affective words. However, Beall and Herbert’s emotional Stroop paradigm differed 
from the current paradigm as their affective words were grey in colour and placed in small font 
over the nose of the face stimuli, hence making the facial expression easier to identify. In 
comparison, our affective words were red in colour and placed diagonally across the entire face, 
possibly making the words easier to identify and resulting in shorter RTs and fewer errors for the 
word instruction set. Additionally, though the same stimuli were used, the current emotional 
Stroop task was altered slightly from that of Ovaysikia et al. (2011) in that the stimulus 
presentations were organized into a block design as opposed to a pseudo-event-related design. 
This change was made in hopes that future collection of fMRI data with this task would result in 
an increased blood oxygen level dependent (BOLD) signal, as a drawback from the pseudo-
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event-related design is that the BOLD signal fluctuates too rapidly, making it hard to measure 
and requiring sophisticated models to predict the BOLD signal for the stimulus. Nonetheless, the 
results obtained from this study demonstrated similar trends to those reported by Ovaysikia et al. 
(2011), corroborating the paradigm as a valid measure of cognitive performance. 
 
 
4.2 Daily Activity Logs 
 
4.2.1 Sleep and Wake Times 
 
 In an attempt to induce internal desynchronization, exogenous melatonin was 
administered to participants in the study over an eight day experimental period. It was found that 
compared to baseline, participants exhibited significant changes to their sleep schedule, with the 
overall average reported sleep time advancing by approximately one hour. Similarly, 
participants’ wake times were altered compared to baseline, with the overall average reported 
wake time advancing by approximately half an hour. Further day-by-day examination of 
participants’ experimental sleep data revealed that all participants’ sleep times occurred earlier 
than average after the first melatonin administration, and sleep times on subsequent days 
followed a pattern of advance or delay when melatonin was administered in the early afternoon 
or late morning, respectively. These results are in line with previous studies that have found that 
doses of exogenous melatonin between 0.3mg and 10mg administered during the afternoon and 
into the early evening decrease the latency of sleep onset after only one day (Dollins et al., 1994; 
Zhdanova et al., 1995). Day-by-day examination of participants’ experimental wake data 
revealed a similar pattern of phase advances and delays as a result of the melatonin treatment, 
though this pattern was not as robust as that found in the sleep data. Additionally, a trend of 
increasing variability was found for both sleep and wake times during the experimental period as 
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compared to a trend of decreasing variability during the baseline period. Though the hypnotic 
effects of melatonin have been widely reported in the literature (for comprehensive reviews of 
melatonin’s hypnotic effects see Zhdanova, 2005 and Srinivasan et al., 2009), this property of 
melatonin cannot fully explain the changes in sleep and wake behaviours demonstrated here. If 
the results were solely due to melatonin’s hypnotic effects, it would be expected that all 
participants’ sleep times consistently advance when given melatonin in the early afternoon and 
consistently delay when given melatonin in the late morning, with no variability throughout. 
Rather, our results are more suggestive of melatonin’s chronobiotic effects, altering participants’ 
sleep and wake patterns and producing increasing variability as a result of participants’ internal 
clocks shifting out of phase with each other and with the external environment, leading to an 
eventual state of internal desynchronization. Consistent with our results, Takahashi et al. (2002) 
and Waterhouse et al. (2003) found that those undergoing jet lag had earlier times of sleep onset 
and offset compared to normal. It was proposed that fatigue in the evening as a result of jet lag 
could account for the earlier sleep times, and the earlier wake times may be due to the poorer 
ability to sleep (Waterhouse et al., 2003). Moreover, night and rotating shift workers have been 
shown to have varying sleep and wake times and a high rate of sleep deprivation, both of which 
are consequences of disrupting circadian rhythmic processes (Haus and Smolensky, 2006). Thus 
it is inferred from previous research together with the current results that our melatonin treatment 
successfully induced circadian disruption, resulting in symptoms commonly associated with jet 
lag and shift work. 
 
4.2.2 Sleep Quality Ratings 
 
 In addition to logging their sleep and wake times, participants were asked to report their 
quality of sleep during both baseline and experimental periods. It was found that participants 
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reported a significantly decreased quality of sleep while on the melatonin treatment compared to 
baseline. Studies on those undergoing jet lag after crossing 10 time zones and shift workers 
working out of phase with their chronotype have similarly demonstrated higher levels of sleep 
disturbance compared to normal (Waterhouse et al., 2003; Juda et al., 2013), indicating that the 
current melatonin protocol induced not only sleep/wake disturbances but also deficits in sleep 
quality commonly observed as consequences of shift work or jet lag. 
 The use of melatonin as a treatment for temporal disturbances has garnered much 
attention from chronobiologists, with the prevailing idea that if taken at the right time, melatonin 
can be effective in helping to re-adapt sleep/wake cycles and improve sleep quality (Arendt et 
al., 1997; Herxheimer and Petrie, 2002; Smith et al., 2005; Zea and Goldstein, 2010). A few 
studies have also demonstrated melatonin’s beneficial effects on those with Alzheimer’s disease, 
with reports of significantly improved sleep quality and decreased number of sleep disturbances 
when melatonin was taken before sleep (Fainstein et al., 1997; Cardinali et al., 2011). The 
present study differs from those aforementioned studies in that melatonin was used in an attempt 
to induce internal desynchrony, with our results demonstrating the first evidence of worse and 
less restful sleeps when taking exogenous melatonin at inappropriate times. This finding holds 
much importance in society today as melatonin is readily marketed and sold as a health product 
and is often taken as a sleep aid by the general public without proper use instructions. As a result 
of taking melatonin at the wrong doses and times, many people likely suffer detrimental side 
effects similar to those observed in the current study. Thus, educating the public on how to 
correctly administer melatonin may be beneficial not only to those undergoing shift work and jet 
lag, but also to those who regularly use melatonin for its soporific effects.  
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4.3 Emotional Stroop Test and Melatonin 
 
 The emotional Stroop task was administered to participants on four days during the 
experimental period to assess changes in cognitive performance as a result of the melatonin 
treatment. It was found that the Stroop effect was eliminated only for RTs in the word instruction 
set, and remained present for RTs in the face instruction set and for errors in both the face and 
word instruction sets. It was further discovered that the congruent face and incongruent word 
conditions demonstrated significant changes between the baseline and experimental periods 
while the incongruent face and congruent word conditions did not. Surprisingly, the only 
condition in which performance significantly decreased during the experimental period was for 
errors in the incongruent word condition; all other conditions demonstrated either no significant 
changes or improved performance on this task. These results are inconsistent with our hypothesis 
and previous research that has demonstrated increased RTs and error rates (Dijk et al., 1992; 
Horowitz et al., 2001; Santhi et al., 2007 and 2008) and falls in alertness and motivation 
(Waterhouse et al., 2005) in shift workers and people experiencing jet lag, as well as changes in 
cognitive throughput performance (Darwent et al., 2010) and slower and more variable RTs in 
the psychomotor vigilance task in people subjected to a forced desynchrony protocol (Zhou et 
al., 2011). In contrast to the simple reactionary tasks used in these studies, however, the 
emotional Stroop task is much more complex, involving the use of higher order cognitive 
functions. To date, the emotional Stroop task has not been employed as a measure of cognitive 
performance in studies on shift work and jet lag, though studies on circadian rhythms and 
conflict processing using the colour/word Stroop task have shown circadian variations in 
components of executive functions including cognitive inhibition and flexibility (i.e. how well 
one adapts to a shift in task criteria) (Marek et al., 2010; Schmidt et al., 2012; Ramirez et al., 
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2012; Garcia et al., 2012). Of particular interest is a study by Bratzke et al. (2012), in which it 
was reported that there were no changes in inhibitory control in the Stroop task over a 40 hour 
constant routine protocol. This finding challenges the predominant view that executive functions 
are particularly vulnerable to sleep loss and changes in circadian rhythms, and may help explain 
why most conditions in our task did not produce significant performance deficits. 
 It is well established in the literature that visual word processing is lateralized to the left 
hemisphere and that face processing is lateralized to the right hemisphere (Maurer et al., 2008; 
Dundas et al., 2013; Li et al., 2013). It has also been postulated by Raccuglia et al. (1997) that 
word and face processing occurs through the dual-pathway hypothesis, an affective computation 
model first described by Joseph LeDoux in 1989. In short, this model purports that affective 
words are addressed through the thalamo-amygdala pathway (also referred to as the “short 
pathway”) and appraised directly, while affective faces are addressed through cortical pathways 
that feed back to the amygdala (also referred to as the “long pathway”) and appraised indirectly 
(Raccuglia et al., 1997). Moreover, word processing has been shown to occur faster and more 
automatically than face processing, as evidenced by the fact that face lateralization occurs at a 
later stage in development than word lateralization (Dundas et al., 2013). Thus in relation to the 
current study, the observed decrease in performance for the word instruction set may have been 
due to the melatonin treatment affecting the subcortical thalamo-amygdala pathway and resulting 
in the less automatic processing of words, as MT1 receptors have been characterized in both 
these areas of the brain. On the other hand, the face processing pathway may have been affected 
to a lesser extent as the cortical pathways may have been able to compensate for this change in 
the amygdala. Facial stimuli processing would therefore be minimally affected, as the cortical 
pathways that result in the conscious impression of these stimuli would still be able to encode the 
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faces presented. It is also thought that participants performed significantly better in the congruent 
face condition during the experimental period as a result of practice – that is, not only were 
participants able to encode the faces without trouble, they were also able to recognize them faster 
due to the fact that they had already performed the emotional Stroop task several times prior. 
This ultimately resulted in faster RTs and less errors compared to baseline. Conversely, 
disruption of the thalamo-amygdala pathway for word processing by the melatonin treatment 
may have caused a trade-off between RTs and error rates, resulting in significantly faster RTs but 
significantly more errors for the incongruent word condition. The incongruent face and 
congruent word conditions demonstrated no significant changes in RTs and error rates between 
the baseline and experimental periods, and it is hypothesized that this occurred because they 
were the hardest and easiest conditions, respectively. It has been shown that incongruent face 
trials for the emotional Stroop task elicit more negative N170 event related potentials than 
congruent face trials (Zhu et al., 2010), potentially because face processing must be enhanced in 
order for a person to overlook the more salient word and give a correct response, a difficult task 
to master. The congruent word trials, on the other hand, were simply too easy – participants 
reached ceiling relatively quickly, thus allowing no room for significant improvements to be 
made. In general, the difficulty levels of these two tasks made them less sensitive to changes in 
performance, with the result being no significant findings when comparing the two testing 
periods.  
 
 
4.4 Diffusion Tensor Imaging 
 
4.4.1 Tract-Based Spatial Statistics and Voxelwise Statistics 
 
 To determine whether the melatonin treatment affected areas in the brain associated with 
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the emotional Stroop task, TBSS and voxelwise statistics were performed on the DTI data. It was 
found that whole brain, left IFG, and right IFG FA values decreased significantly during the 
experimental period while whole brain, left IFG, and right IFG MD values increased 
significantly compared to baseline. Whole brain FA and MD values have been shown to increase 
in the morning and decrease in the evening, perhaps as an adaptation of neural activities to the 
environmental light/dark cycle (Jiang et al., 2014). Indeed, neural activities are performed more 
regularly during the daytime relative to the evening, and the subsequent increase in FA and MD 
values in the morning may indicate improved functional performance (Jiang et al., 2014). 
Comparatively, our results show a decrease in FA values and an increase in MD values between 
the baseline and experimental scans, though the time of scanning was kept consistent for all time 
points and participants. Circadian variations in these DTI metrics can be thus ruled out, and the 
observed changes may instead be due to the melatonin treatment and its effects on the pathways 
underlying performance on the emotional Stroop task.  
 Although no studies to date have used DTI as a tool for understanding the neural 
networks associated with the emotional Stroop task, other studies using memory and inhibition 
tasks have demonstrated correlations between DTI metrics and task performance in some 
common brain areas. For example, a study by Sasson et al. (2010) in which participants 
performed a non-verbal memory task found a large accuracy- and RT-MD correlation in the IFG. 
It was shown that shorter RTs and less errors were correlated with increased FA and decreased 
MD values, potentially because dendritic density and synaptic spines were reduced and the 
higher organization and integrity of white matter allowed for faster transmission of information 
in the associated brain networks (Sasson et al., 2010). Moreover, Madsen et al. (2010) found that 
faster response inhibition in the go/no go task was significantly associated with higher FA and 
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lower MD values in the IFG, possibly reflecting the faster speed of neural conduction as a result 
of better myelinated or more densely packed fibre tracts. In the present study, it was 
demonstrated that overall, participants had shorter RTs and less errors during the experimental 
period but decreased FA and increased MD values in the IFG. In general, higher MD and lower 
FA values indicate impaired fibre integrity due to an increased rate of diffusion and loss of 
coherence on the principle diffusion axis (Soares et al., 2013). It is therefore hypothesized that 
though participants may be performing better on the task due to task repetition, underlying 
pathways are being disrupted as evidenced by the changes in DTI metrics observed.  
 It may be argued that eight days is a relatively short period of time for changes in the 
brain to occur. However, a study by Sagi et al. (2012) demonstrated structural changes in the 
brain within two hours of learning a new video game. They also performed a concomitant study 
on rats learning a Morris water maze and found that spatial learning was associated with a 
decrease in MD values within the hippocampus detected the following day (Sagi et al., 2012). 
Because DTI is used to determine tissue microstructure, increases or decreases in tissue density 
and enhancement or deterioration of tissue organization will lead to changes in water diffusion 
properties (Assaf and Pasternak, 2008). It is thus postulated that the decrease in MD values may 
be a result of rapid activity-dependent astrocyte swelling, reflecting a shift in the ratio of 
extracellular to intracellular space (Sagi et al., 2012). In the current study, it was hypothesized 
that changes in DTI metrics would be found in the left and right HEC, though analysis of the 
results identified no significant changes in FA and MD values. In comparison to the video game 
task used by Sagi et al. (2012), the emotional Stroop task employed in our study does not require 
spatial navigation and may thus need to recruit fewer resources from the hippocampus. As a 
result, it is proposed that the eight day melatonin treatment combined with the eight time points 
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of emotional Stroop task administration may indeed be too short of a time frame for changes in 
the hippocampus to be observed. Extending the experimental period for a longer amount of time 
or altering the task to involve aspects of spatial learning may produce the significant changes in 
DTI metrics initially expected within the hippocampus. 
 
4.4.2 Tractography 
 
 Changes in white matter microstructure were also assessed in this study via the use of 
probabilistic tractography. No significant changes were found in the number of valid tracts 
between the left HEC and the left and right IFG nor between the right HEC and the left and right 
IFG when comparing baseline and experimental scans. Several factors are thought to have 
contributed to these non-significant findings. Firstly, as tractography is influenced by many 
anatomy- and algorithm-based factors (Jones et al., 2012), our small sample size of 10 
participants may have affected the results. Furthermore, as tractography is sensitive to ROI size 
and placement (Jones et al., 2012), the masks of the ROIs generated from the standard atlases 
provided by FSL may have lacked specificity and consistency across participants. Future studies 
will extract ROIs from individual participant’s functional data and apply it directly to the DTI 
data to ensure a more accurate comparison between these regions and their streamline counts. 
Though studies on response inhibition have characterized a network of fibre tracts between the 
IFG, presupplementary motor area, and the basal ganglia, specifically the subthalamic nuclei 
(Aron et al., 2007; Leh et al., 2007; King et al., 2012; Swann et al., 2012) and studies on 
learning and memory encoding have found fibre tracts connecting the prefrontal cortex, 
hippocampus and basal ganglia (Bennett et al., 2011; Schott et al., 2011), no studies to date have 
looked at the direct connections between the hippocampus and the IFG. Thus it is not known 
whether the lack of change in SC values found is a result of the paradigm used, or whether these 
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fibres are particularly resistant to change. Future work will look to clarify these results by 
incorporating additional ROIs (such as the presupplementary motor area, basal ganglia, and 
retinal pathways to the SCN, and amygdala and hippocampus pathways to the IFG) into the 
current tractography analysis and specifically targeting the hippocampus and IFG by modifying 
the cognitive task to include aspects of both inhibition and memory encoding. 
 
 
4.5 Correlations 
 
Correlation analyses were performed on the sleep, wake, sleep quality, emotional Stroop, 
and DTI data to determine whether there were any associations between the behavioural, 
attentional, and neural components of the study. It was found that increases in incongruent word 
errors in the emotional Stroop task were significantly correlated with decreases in left 
hemisphere IFG FA values. As mentioned in section 4.3, word processing is known to be 
lateralized to the left hemisphere (Dundas et al., 2013; Li et al., 2013). Thus the decrease in left 
hemisphere IFG FA values may explain why increases in incongruent word errors were found, as 
FA values closer to zero indicate poorer alignment of fibres and therefore less streamlined 
connections (Jones et al., 2012). Additionally, it was found that decreases in congruent face 
errors in the emotional Stroop task were significantly correlated with decreases in both right 
hemisphere IFG FA and MD values. This was an interesting finding, as FA and MD values often 
have an inverse relationship – that is, an increase in one metric is regularly accompanied by a 
decrease in the other, and vice versa (Soares et al., 2013). It was thus expected that FA values 
would increase while MD values decreased in the right IFG, as this indicates more efficient fibre 
organization and more streamlined connections. That this was not the case may again be 
explained by the fact that, as mentioned in section 4.3, face processing occurs through several 
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cortical pathways which feedback into the amygdala (Raccuglia et al., 1997). Therefore although 
there were poorer organization of fibres in the right IFG as inferred by the decrease in FA found, 
other brain regions involved in the face processing pathway may have overcompensated to allow 
for more accurate face encoding, resulting in fewer errors in the congruent face condition. 
 
 
4.6 Limitations and Future Work 
 
 Several limitations are present in this study. Firstly, we were not able to recruit enough 
participants to have a completely separate control population; thus the control group consisted 
only of within-subject controls. Future work will incorporate a sample of independent, healthy 
controls who will be given placebos to parse out what effects are due to learning and what effects 
are due to the melatonin treatment alone. Furthermore, only two scans were conducted for each 
participant – one at the end of the baseline period and one at the end of the experimental period. 
Incorporating a third scan prior to exposure to the emotional Stroop task could have perhaps 
provided insight into the structural make-up prior to learning, allowing for a clearer 
determination of learning versus desynchrony effects on the brain. Moreover, external factors 
that may have affected the results could not be controlled for in this study as participants were 
not secluded in a laboratory setting for the duration of the experiment. Additionally, we did not 
include shift workers or people undergoing jet lag to test how the current desynchrony model 
compares to internal desynchronization caused by temporal disruption. Future studies will 
incorporate a subset of these populations to determine how accurate and effective melatonin is at 
causing circadian disruption and the associated deficits in cognitive performance. As mentioned 
previously, the emotional Stroop task used in this study may not have been challenging enough 
to discriminate between minor differences in baseline and experimental performance. Future 
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studies using this paradigm can alter the pictures to make them greyscale so that neither the face 
nor the word stimuli are more salient than the other, or shorten the stimulus presentation times to 
create a more sensitive titer to examine cognitive performance. Also, though the eight days of 
melatonin-induced desynchrony produced observable results, a longer period of 
desynchronization may lend more insight into how circadian disruption affects cognitive 
processes and the associated structural networks in the brain. Methodologically, tractography 
analysis using DTI data does not take into consideration crossing, diverging, or kissing fibres. 
Thus regions of the brain containing voxels that have two or more fibre bundles oriented in 
different directions may lead to incorrect estimation of fibre directions and may even result in the 
abrupt termination of fibre tracts (Soares et al., 2013). Alternatives to DTI tractography include 
more sophisticated approaches such as diffusion spectrum imaging and Q-ball imaging, which 
use probability density functions instead of single tensors to identify diffusion in different 
directions at each voxel (Soares et al., 2013). Lastly, though the ELISAs were not performed on 
the full set of collected data due to financial constraints, melatonin measurements via saliva 
sample collections were restricted to waking hours only. Analysis of these samples will therefore 
need to model the data for nighttime hours, when melatonin levels are generally at their highest 
point.  
 
 
4.7 Applications: Alzheimer’s and Parkinson’s Disease 
 
As demonstrated in the present study, melatonin taken at inappropriate times during the 
day can elicit behavioural changes similar to those exhibited by people undergoing temporal 
disruption. However, proper administration of melatonin can have many positive effects. For 
example, melatonin’s antioxidant properties have been shown to prevent oxidative damage in 
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cultured neuronal cells (Mayo et al., 1998) as well as in the brains of animals treated with 
neurotoxic agents (Jin et al., 1998), lending favour towards its use as a potential therapeutic drug 
for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD). 
Indeed, studies on AD and PD patients have found that melatonin supplements not only aid in 
reducing sleep/wake disturbances (for a comprehensive review on sleep disturbances in AD and 
PD patients see Rothman and Mattson, 2012), but may also play a role in slowing down the 
progression of these diseases (for a comprehensive review on the therapeutic uses of melatonin 
see Pandi-Perumal et al., 2013). In addition, Adi et al. (2010) found that MT1 and MT2 receptors 
are down-regulated in the amygdala and substantia nigra of PD patients, providing further 
evidence of the possible involvement of melatonin in the development of PD. Thus it is of 
extreme importance to understand the role of melatonin not only in the circadian system, but also 
in the development and treatment of AD and PD. 
The use of DTI may also be a good tool to uncover changes in white matter 
microstructure in AD and PD patients. Hasan et al. (2012) found that in people with AD, fibre 
paths from the hippocampus towards the amygdala, thalamus, and caudate and from these 
regions back to the hippocampus were more scattered and had less neurotransmitters than that of 
controls. Moreover, Baggio et al. (2012) found significant positive correlations between 
performance in identifying sad facial expressions and FA levels in the right frontal lobe, inferior 
fronto-occipital fasciculus, and inferior longitudinal fasciculus of PD patients. Tractography 
studies on healthy controls have found fibres that connect the hippocampus and the amygdala 
and that extend to the fornix, dorsal hippocampal commissure, stria terminalis, uncinate 
fasciculus and the orbitofrontal cortex (Colnat-Coulbois et al., 2010), some of which are regions 
of the brain that are known to be affected by AD and PD. Therefore, administration of properly 
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timed melatonin treatment along with the emotional Stroop task to people with AD and PD in 
combination with DTI and tractography analyses may provide insight into the structural changes 
underlying the cognitive impairment associated with these diseases.  
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5. Conclusion 
 
The present study demonstrates the first evidence of the effects of inappropriately timed 
melatonin on cognitive performance and structural changes in the brain. While we did not find 
increases in RTs and error rates on all conditions of the emotional Stroop task as we had 
hypothesized, we did find decreases in FA and increases in MD values in the IFG, consistent 
with signs of impaired fibre integrity. Thus the current work demonstrates that though short-term 
desynchronization may not always produce observable deficits in performance on cognitive 
tasks, brain networks underlying executive functions show disruption after only eight days of 
melatonin treatment. Long-term internal desynchronization as a result of shift work or constant 
jet lag may therefore lead to negative white matter microstructure adaptations that can further 
impair cognitive performance. In addition, this study is also the first to demonstrate that 
melatonin can effectively induce circadian desynchronization as evidenced by the changes in 
sleep/wake behaviours reported by our participants. Unexpectedly, participants also reported 
significant decreases in sleep quality during the melatonin treatment period. It is thus beneficial 
to educate the general public on the proper use of melatonin as a sleep aid, as taking melatonin at 
inappropriate times may in fact be doing more harm than good. Further studies need to be 
conducted using populations of shift workers and frequent sufferers of jet lag to assess whether 
similar structural changes in the brain occur in those undergoing internal desynchronization as a 
result of temporal disruption.  
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Appendix A – Timeline of Data Collection !
Baseline period data collection: 
 ! !!!!!!!!!
Experimental period data collection: 
 
 !!!! !
2 weeks of 
daily activity 
logs 
2 days of 
emotional Stroop 
testing 
3 days of saliva 
collection + 2 days of 
emotional Stroop testing 
Scanning session #1 
(within 2 weeks of last 
emotional Stroop test) 
8 pills (one per day) + 8 
days of saliva collection 
+ 4 days of emotional 
Stroop testing 
Scanning session #2 (on 
the last day of pill 
administration + saliva 
collection) 
! 110 
Appendix B – MCTQ Results 
 
!
!
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Appendix C – Protocol for Pill Administration 
 
Please read the following instructions carefully before administering the pills. You are expected 
to follow the timeline exactly as outlined below. 
 
1. Eight (8) pills have been provided for you to take over the course of eight (8) days (one pill a 
day). 
 
2. To take these pills, please place the entire pill under your tongue and wait for it to dissolve 
completely. The pill should take approximately five (5) minutes to dissolve. 
 
3. Within 5 minutes of taking the pill, please provide a saliva sample and mark it on your saliva 
protocol sheet with an asterisk (*). This will allow the researcher to identify the saliva sample 
given directly after administration of the pill. 
 
Thank you! 
 
Day of Pill Administration Time of Pill Administration 
1 6:30pm 
2 5:00pm 
3 8:30am 
4 10:00am 
5 6:30pm 
6 5:00pm 
7 8:30am 
8 10:00am !! !
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Appendix D – Instructions for Saliva Collection 
 
Please read the following instructions carefully before starting the saliva collection process. The 
more carefully you follow the instructions, the more reliable the results obtained from your 
samples will be. 
 
1. Before starting collection, ensure that the number on your collection container matches the 
one in the attached protocol. 
 
2. 5 minutes before each saliva collection, rinse your mouth thoroughly with cold water. 
Nothing should be eaten during the collection time. The last drink and meal should be taken 
at least 15 minutes prior to starting the collection. Chewing gum and brushing teeth should 
also be avoided in the 15 minutes prior to collection. Refrain from drinks containing artificial 
colorants, caffeine or alcohol on the days of collection. If possible, no aspirin and medicines 
that contain ibuprofen should be taken on collection days. 
 
3. When it is time for your saliva to be collected, deposit your saliva into the container. You 
must provide a minimum of 1mL per collection. There are markings on the side of the 
collection container to use as reference points.  
 
4. When finished, close the top of the tube and place in the box provided. Store the box 
containing the samples in the freezer at -20˚C. Repeat steps 1 – 4 for each collection. Refer 
back to the protocol provided for dates and times of each collection. 
 
5. Please bring your collected samples to the researcher on day three of collection. If possible, 
try to minimize the time the collected samples remain above the -20˚C range. 
 
Thank you!!! !
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Appendix E – Timeline for Saliva Collection!
 
Please follow the protocol outlined below for saliva sample collection. The schedule for saliva 
collection, along with the sample number that you will need to match to your collection 
container, is as follows: 
 
Day 1 – Sunday, November 17th, 2013 
 
Collection Time Sample # 
8:30 am 1 
9:00 am 2 
9:30 am 3 
10:00 am 4 
1:30 pm 5 
5:00 pm 6 
6:00 pm 7 
7:00 pm 8 
8:00 pm 9 
8:30 pm 10 
9:00 pm 11 
9:30 pm 12 
10:00 pm 13 
10:30 pm 14 
11:00 pm 15 
11:30 pm 16 
12:00 am 17 
12:30 am 18 
*1:00 am *19 
 *1:30 am *20 
 
* The starred sample times indicate times at which you do not need to provide samples if you are 
not awake. If you do happen to either wake up before the indicated collection time or sleep after 
the last collection time for the day, please feel free to provide more samples at your convenience. 
If you do choose to provide extra samples, please adjust the sample numbers accordingly. Thank 
you! 
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Day 2 – Monday, November 18th, 2013 
 
Collection Time Sample # 
8:30 am 21 
9:00 am 22 
9:30 am 23 
10:00 am 24 
1:30 pm 25 
5:00 pm 26 
6:00 pm 27 
7:00 pm 28 
8:00 pm 29 
8:30 pm 30 
9:00 pm 31 
9:30 pm 32 
10:00 pm 33 
10:30 pm 34 
11:00 pm 35 
11:30 pm 36 
12:00 am 37 
12:30 am 38 
*1:00 am *39 
 *1:30 am *40 
 
* The starred sample times indicate times at which you do not need to provide samples if you are 
not awake. If you do happen to either wake up before the indicated collection time or sleep after 
the last collection time for the day, please feel free to provide more samples at your convenience. 
If you do choose to provide extra samples, please adjust the sample numbers accordingly. Thank 
you! 
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Day 3 – Tuesday, November 19th, 2013 
 
Collection Time Sample # 
8:30 am 41 
9:00 am 42 
9:30 am 43 
10:00 am 44 
1:30 pm 45 
5:00 pm 46 
6:00 pm 47 
7:00 pm 48 
8:00 pm 49 
8:30 pm 50 
9:00 pm 51 
9:30 pm 52 
10:00 pm 53 
10:30 pm 54 
11:00 pm 55 
11:30 pm 56 
12:00 am 57 
12:30 am 58 
*1:00 am *59 
 *1:30 am *60 
 
* The starred sample times indicate times at which you do not need to provide samples if you are 
not awake. If you do happen to either wake up before the indicated collection time or sleep after 
the last collection time for the day, please feel free to provide more samples at your convenience. 
If you do choose to provide extra samples, please adjust the sample numbers accordingly. Thank 
you! 
 !!!!!!! !
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Appendix F – Statistical Tables!
 
 
Table 1. Paired samples t-test for the RTs and errors of the face and word instruction sets. Pre = 
baseline; F = face instruction; W = word instruction; RT = reaction times; Err = errors. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval of 
the Difference 
Lower Upper 
Pair 1 
Pre_F_RT - 
Pre_W_RT 
143.060017 43.1164075 13.6346052 112.2163980 173.9036378 10.492 9 .000 
Pair 2 
Pre_F_Err - 
Pre_W_Err 
2.4166667 1.6347641 .5169578 1.2472269 3.5861065 4.675 9 .001 
 
 
 
Table 2. Paired samples t-test for the RTs and errors of the face and word instruction sets during the 
baseline period, with each instruction broken down into its component congruent and incongruent trials. 
Con = congruent condition; Incon = incongruent condition; F = face instruction; W = word instruction; 
RT = reaction times; Err = errors. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 
Con_F_RT - 
Incon_F_RT 
-77.423220 51.191052 16.188032 -114.043092 -40.803347 -4.783 9 .001 
Pair 2 
Con_W_RT - 
Incon_W_RT 
-11.951567 16.033003 5.0700809 -23.4208873 -.4822477 -2.357 9 .043 
Pair 3 
Con_F_Err - 
Incon_F_Err 
-5.1750000 3.0732945 .9718610 -7.3735024 -2.9764976 -5.325 9 .000 
Pair 4 
Con_W_Err - 
Incon_W_Err 
-1.2750000 .7945124 .2512469 -1.8433600 -.7066400 -5.075 9 .001 
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Table 3. Paired samples t-test for sleep times in the baseline and experimental periods. Baseline_Sleep = 
baseline sleep times; Experimental_Sleep = experimental sleep times. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
Baseline_Sleep - 
Experimental_Sleep 
.787500 .8454586 .2673575 .18269531 1.3923046 2.945 9 .016 
 
 
 
Table 4. Paired samples t-test for wake times in the baseline and experimental periods. Baseline_Wake 
= baseline wake times; Experimental_Wake = experimental wake times. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 
1 
Baseline_Wake - 
Experimental_Wake 
.37000000 .65420515 .20687783 -.097990 .83799017 1.788 9 .107 
 
 
 
Table 5. Linear mixed models test for sleep quality ratings in the baseline and experimental periods. 
Parameter Estimate Std. Error df t Sig. 95% Confidence Interval 
Lower Bound Upper Bound 
Intercept 3.232143 .137174 118 23.562 .000 2.960500 3.503786 
[Condition=1] .564732 .187834 118 3.007 .003 .192770 .936694 
[Condition=2] 0a 0 . . . . . 
Dependent Variable: Sleep Rating. 
a. This parameter is set to zero because it is redundant. 
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Table 6. Paired samples t-test for the RTs and errors of the face and word instruction sets during the 
experimental period, with each instruction broken down into its component congruent and incongruent 
trials. Con = congruent condition; Incon = incongruent condition; F = face instruction; W = word 
instruction; RT = reaction times; Err = errors. 
 Paired Differences t df Sig. 
2-
tailed 
Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence Interval 
of the Difference 
Lower Upper 
Pair 1 
Con_F_RT - 
Incon_F_RT 
-101.55392 64.5789349 20.421652 -147.750913 -55.356939 -4.973 9 .001 
Pair 2 
Con_W_RT - 
Incon_W_RT 
-4.2507308 15.2696532 4.8286883 -15.1739827 6.6725211 -.880 9 .402 
Pair 3 
Con_F_Err - 
Incon_F_Err 
-4.9166666 3.06337384 .96872386 -7.10807230 -2.7252610 -5.075 9 .001 
Pair 4 
Con_W_Err - 
Incon_W_Err 
-1.8000000 .69522179 .21984843 -2.29733171 -1.3026682 -8.187 9 .000 
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Table 7. Paired samples t-test for the RTs and errors of the face and word instruction sets comparing 
baseline and experimental periods, with each instruction broken down into its component congruent and 
incongruent trials. Pre = baseline; Post = experimental; Con = congruent; Incon = incongruent; F = face; 
W = word; RT = reaction times; Err = errors. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
Pre_Con_F_RT - 
Post_Con_F_RT 
39.213064 51.16025 16.178293 2.61522074 75.810907 2.424 9 .038 
Pair 2 
Pre_Incon_F_RT - 
Post_Incon_F_RT 
15.082357 23.309351 7.3710641 -1.5921480 31.756863 2.046 9 .071 
Pair 3 
Pre_Con_W_RT - 
Post_Con_W_RT 
23.633802 34.091169 10.780574 -.75355114 48.021156 2.192 9 .056 
Pair 4 
Pre_Incon_W_RT - 
Post_Incon_W_RT 
31.334639 31.633564 10.003411 8.70535043 53.963927 3.132 9 .012 
Pair 5 
Pre_Con_F_Err - 
Post_Con_F_Err 
.62500000 .89170561 .28198207 -.01288776 1.2628877 2.216 9 .054 
Pair 6 
Pre_Incon_F_Err - 
Post_Incon_F_Err 
.88333333 2.4611800 .77829348 -.87728884 2.6439555 1.135 9 .286 
Pair 7 
Pre_Con_W_Err - 
Post_Con_W_Err 
.01666667 .37018514 .11706282 -.24814783 .28148116 .142 9 .890 
Pair 8 
Pre_Incon_W_Err - 
Post_Incon_W_Err 
-.5083333 .73958822 .23387833 -1.0374028 .02073621 -2.173 9 .054 
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Table 8. Repeated measures ANOVA for the RTs outcome. Three within-subject factors of period, 
congruency, and instruction were used, with two levels in each factor (baseline and experimental, 
congruent and incongruent, and face and word, respectively). Interactions between the different factors 
are also shown. 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Partial 
Eta 
Squared 
Period 
Sphericity Assumed 14923.240 1 14923.240 7.406 .024 .451 
Greenhouse-Geisser 14923.240 1.000 14923.240 7.406 .024 .451 
Huynh-Feldt 14923.240 1.000 14923.240 7.406 .024 .451 
Lower-bound 14923.240 1.000 14923.240 7.406 .024 .451 
Error (Period) 
Sphericity Assumed 18135.020 9 2015.002    
Greenhouse-Geisser 18135.020 9.000 2015.002    
Huynh-Feldt 18135.020 9.000 2015.002    
Lower-bound 18135.020 9.000 2015.002    
Congruency 
Sphericity Assumed 47618.770 1 47618.770 31.835 .000 .780 
Greenhouse-Geisser 47618.770 1.000 47618.770 31.835 .000 .780 
Huynh-Feldt 47618.770 1.000 47618.770 31.835 .000 .780 
Lower-bound 47618.770 1.000 47618.770 31.835 .000 .780 
Error 
(Congruency) 
Sphericity Assumed 13462.404 9 1495.823    
Greenhouse-Geisser 13462.404 9.000 1495.823    
Huynh-Feldt 13462.404 9.000 1495.823    
Lower-bound 13462.404 9.000 1495.823    
Instruction 
Sphericity Assumed 415655.180 1 415655.180 121.543 .000 .931 
Greenhouse-Geisser 415655.180 1.000 415655.180 121.543 .000 .931 
Huynh-Feldt 415655.180 1.000 415655.180 121.543 .000 .931 
Lower-bound 415655.180 1.000 415655.180 121.543 .000 .931 
Error (Instruction) 
Sphericity Assumed 30778.411 9 3419.823    
Greenhouse-Geisser 30778.411 9.000 3419.823    
Huynh-Feldt 30778.411 9.000 3419.823    
Lower-bound 30778.411 9.000 3419.823    
Period * 
Congruency 
Sphericity Assumed 337.426 1 337.426 1.206 .301 .118 
Greenhouse-Geisser 337.426 1.000 337.426 1.206 .301 .118 
Huynh-Feldt 337.426 1.000 337.426 1.206 .301 .118 
Lower-bound 337.426 1.000 337.426 1.206 .301 .118 
Error (Period * 
Congruency) 
Sphericity Assumed 2517.637 9 279.737    
Greenhouse-Geisser 2517.637 9.000 279.737    
Huynh-Feldt 2517.637 9.000 279.737    
Lower-bound 2517.637 9.000 279.737    
Period * Sphericity Assumed .566 1 .566 .005 .946 .001 
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Instruction Greenhouse-Geisser .566 1.000 .566 .005 .946 .001 
Huynh-Feldt .566 1.000 .566 .005 .946 .001 
Lower-bound .566 1.000 .566 .005 .946 .001 
Error (Period * 
Instruction) 
Sphericity Assumed 1052.121 9 116.902    
Greenhouse-Geisser 1052.121 9.000 116.902    
Huynh-Feldt 1052.121 9.000 116.902    
Lower-bound 1052.121 9.000 116.902    
Congruency * 
Instruction 
Sphericity Assumed 33119.564 1 33119.564 20.509 .001 .695 
Greenhouse-Geisser 33119.564 1.000 33119.564 20.509 .001 .695 
Huynh-Feldt 33119.564 1.000 33119.564 20.509 .001 .695 
Lower-bound 33119.564 1.000 33119.564 20.509 .001 .695 
Error (Congruency 
* Instruction) 
Sphericity Assumed 14533.911 9 1614.879    
Greenhouse-Geisser 14533.911 9.000 1614.879    
Huynh-Feldt 14533.911 9.000 1614.879    
Lower-bound 14533.911 9.000 1614.879    
Period * 
Congruency * 
Instruction 
Sphericity Assumed 1266.559 1 1266.559 5.063 .051 .360 
Greenhouse-Geisser 1266.559 1.000 1266.559 5.063 .051 .360 
Huynh-Feldt 1266.559 1.000 1266.559 5.063 .051 .360 
Lower-bound 1266.559 1.000 1266.559 5.063 .051 .360 
Error (Period * 
Congruency * 
Instruction) 
Sphericity Assumed 2251.368 9 250.152    
Greenhouse-Geisser 2251.368 9.000 250.152    
Huynh-Feldt 2251.368 9.000 250.152    
Lower-bound 2251.368 9.000 250.152    
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Table 9. Repeated measures ANOVA for the errors outcome. Three within-subject factors of period, 
congruency, and instruction were used, with two levels in each factor (baseline and experimental, 
congruent and incongruent, and face and word, respectively). Interactions between the different factors 
are also shown. 
Source Type III Sum 
of Squares 
df Mean 
Square 
F Sig. Partial 
Eta 
Squared 
Period 
Sphericity Assumed 1.292 1 1.292 .999 .344 .100 
Greenhouse-Geisser 1.292 1.000 1.292 .999 .344 .100 
Huynh-Feldt 1.292 1.000 1.292 .999 .344 .100 
Lower-bound 1.292 1.000 1.292 .999 .344 .100 
Error (Period) 
Sphericity Assumed 11.644 9 1.294    
Greenhouse-Geisser 11.644 9.000 1.294    
Huynh-Feldt 11.644 9.000 1.294    
Lower-bound 11.644 9.000 1.294    
Congruency 
Sphericity Assumed 216.701 1 216.701 38.881 .000 .812 
Greenhouse-Geisser 216.701 1.000 216.701 38.881 .000 .812 
Huynh-Feldt 216.701 1.000 216.701 38.881 .000 .812 
Lower-bound 216.701 1.000 216.701 38.881 .000 .812 
Error 
(Congruency) 
Sphericity Assumed 50.161 9 5.573    
Greenhouse-Geisser 50.161 9.000 5.573    
Huynh-Feldt 50.161 9.000 5.573    
Lower-bound 50.161 9.000 5.573    
Instruction 
Sphericity Assumed 108.113 1 108.113 22.613 .001 .715 
Greenhouse-Geisser 108.113 1.000 108.113 22.613 .001 .715 
Huynh-Feldt 108.113 1.000 108.113 22.613 .001 .715 
Lower-bound 108.113 1.000 108.113 22.613 .001 .715 
Error (Instruction) 
Sphericity Assumed 43.028 9 4.781    
Greenhouse-Geisser 43.028 9.000 4.781    
Huynh-Feldt 43.028 9.000 4.781    
Lower-bound 43.028 9.000 4.781    
Period * 
Congruency 
Sphericity Assumed .089 1 .089 .150 .707 .016 
Greenhouse-Geisser .089 1.000 .089 .150 .707 .016 
Huynh-Feldt .089 1.000 .089 .150 .707 .016 
Lower-bound .089 1.000 .089 .150 .707 .016 
Error (Period * 
Congruency) 
Sphericity Assumed 5.316 9 .591    
Greenhouse-Geisser 5.316 9.000 .591    
Huynh-Feldt 5.316 9.000 .591    
Lower-bound 5.316 9.000 .591    
Period * Sphericity Assumed 5.000 1 5.000 3.929 .079 .304 
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Instruction Greenhouse-Geisser 5.000 1.000 5.000 3.929 .079 .304 
Huynh-Feldt 5.000 1.000 5.000 3.929 .079 .304 
Lower-bound 5.000 1.000 5.000 3.929 .079 .304 
Error (Period * 
Instruction) 
Sphericity Assumed 11.453 9 1.273    
Greenhouse-Geisser 11.453 9.000 1.273    
Huynh-Feldt 11.453 9.000 1.273    
Lower-bound 11.453 9.000 1.273    
Congruency * 
Instruction 
Sphericity Assumed 61.542 1 61.542 19.253 .002 .681 
Greenhouse-Geisser 61.542 1.000 61.542 19.253 .002 .681 
Huynh-Feldt 61.542 1.000 61.542 19.253 .002 .681 
Lower-bound 61.542 1.000 61.542 19.253 .002 .681 
Error (Congruency 
* Instruction) 
Sphericity Assumed 28.769 9 3.197    
Greenhouse-Geisser 28.769 9.000 3.197    
Huynh-Feldt 28.769 9.000 3.197    
Lower-bound 28.769 9.000 3.197    
Period * 
Congruency * 
Instruction 
Sphericity Assumed .767 1 .767 1.255 .292 .122 
Greenhouse-Geisser .767 1.000 .767 1.255 .292 .122 
Huynh-Feldt .767 1.000 .767 1.255 .292 .122 
Lower-bound .767 1.000 .767 1.255 .292 .122 
Error (Period * 
Congruency * 
Instruction) 
Sphericity Assumed 5.502 9 .611    
Greenhouse-Geisser 5.502 9.000 .611    
Huynh-Feldt 5.502 9.000 .611    
Lower-bound 5.502 9.000 .611    
 
Table 10. Paired samples t-test for the whole brain, left IFG and right IFG comparing baseline and 
experimental FA values. FA = fractional anisotropy value; Whole = whole brain; LeftIFG = left inferior 
frontal gyrus; RightIFG = right inferior frontal gyrus; Pre = baseline; Post = experimental. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
FA_Whole_Pre -
FA_Whole_Post 
.050125277 .01663611 .00526080 .0382245 .062026 9.528 9 .000 
Pair 2 
FA_LeftIFG_Pre - 
FA_LeftIFG_Post 
.096077154 .05816812 .01839437 .0544661 .137688 5.223 9 .001 
Pair 3 
FA_RightIFG_Pre - 
FA_RightIFG_Post 
.070671049 .07467109 .02361307 .0172545 .124087 2.993 9 .015 
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Table 11. Paired samples t-test for the whole brain, left IFG and right IFG comparing baseline and 
experimental MD values. MD = mean diffusivity value; Whole = whole brain; LeftIFG = left inferior 
frontal gyrus; RightIFG = right inferior frontal gyrus; Pre = baseline; Post = experimental. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. 
Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
MD_Whole_Pre - 
MD_Whole_Post 
-.00005335 .00002087 .0000066 -.000068 -.0000384 -8.082 9 .000 
Pair 2 
MD_LeftIFG_Pre - 
MD_LeftIFG_Post 
-.00002873 .00004032 .0000127 -.000057 .00000010 -2.254 9 .051 
Pair 3 
MD_RightIFG_Pre - 
MD_RightIFG_Post 
-.00004849 .00004196 .0000132 -.000078 -.0000184 -3.655 9 .005 
 
 
 
Table 12. Paired samples t-test for the baseline and experimental periods comparing right and left 
hemisphere SC values. Pre = baseline; Post = experimental; L = left hemisphere; R = right hemisphere; 
HEC = hippocampal entorhinal cortex. 
 Paired Differences t df Sig. 2-
tailed Mean Std. 
Deviation 
Std. Error 
Mean 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pair 1 
Pre_L_HEC - 
Post_L_HEC 
-22.9000 98.83145 31.25325 -93.59976 47.79976 -.733 9 .482 
Pair 2 
Pre_R_HEC - 
Post_R_HEC 
-18.0000 172.33623 54.49750 -141.2819 105.28192 -.330 9 .749 
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Table 13. Correlation statistics for the congruent face error and right IFG FA pairing. Con = congruent 
condition; F = face instruction; Err = errors; Right = right hemisphere; IFG = inferior frontal gyrus; FA 
= fractional anisotropy value. 
 Con_F_Err Right_IFG_FA 
Con_F_Err 
Pearson Correlation 1 .822** 
Sig. 2-tailed  .004 
N 10 10 
Right_IFG_FA 
Pearson Correlation .822** 1 
Sig. 2-tailed .004  
N 10 10 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
 
 
 
 
Table 14. Correlation statistics for the congruent face error and right IFG MD pairing. Con = congruent 
condition; face = face instruction; Err = errors; Right = right hemisphere; IFG = inferior frontal gyrus; 
MD = mean diffusivity value. 
 Con_F_Err Right_IFG_MD 
Con_F_Err 
Pearson Correlation 1 .684* 
Sig. 2-tailed  .029 
N 10 10 
Right_IFG_MD 
Pearson Correlation .684* 1 
Sig. 2-tailed .029  
N 10 10 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Table 15. Correlation statistics for the incongruent word error and left IFG FA pairing. Incon = 
incongruent condition; W = word instruction; Err = errors; Left = left hemisphere; IFG = inferior frontal 
gyrus; FA = fractional anisotropy value. 
 Incon_W_Err Left_IFG_FA 
Incon_W_Err 
Pearson Correlation 1 -.743* 
Sig. 2-tailed  .014 
N 10 10 
Left_IFG_FA 
Pearson Correlation -.743* 1 
Sig. 2-tailed .014  
N 10 10 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix G – ELISA Proof of Concept!
 
As a biological measure of internal desynchrony, melatonin levels in participants’ 
baseline and experimental saliva samples were to be measured. However, due to unforeseen 
circumstances regarding issues with funding (see Appendix H breakdown of costs), data were 
only analyzed from two participants’ baseline collections (Figures A-1 and A-2). As such, the 
results shown below should be regarded only as a proof of concept for the two participants, and 
future analyses on the remaining participants’ samples and discussion of the salivary melatonin 
data will be excluded from this thesis. The remaining samples will be kept frozen in storage for 
analysis at a later date. Note that the concentrations of melatonin presented in Figures A-1 and 
A-2 are higher than what would normally be found in saliva, and thus future experiments will 
include the performance of serial dilations and the re-analysis of these samples. 
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Figure A-1. Compiled baseline data for Subject 1. The graph represents the subject’s baseline melatonin 
profile, generated from three days of saliva samples. The red circles represent the times at which samples 
were taken relative to DLMO (time 0), as well as the resulting concentration of melatonin in pg/ml 
(determined using an ELISA). The blue line represents a sinusoidal fit to the data points. The black bar at 
the bottom represents the subject’s average sleep time relative to DLMO. The blue bars represent the 
average range of times of breakfast, lunch and dinner relative to DLMO. The red arrow indicates the time 
at which the subject performed the emotional Stroop task on days 2 and 3 of saliva collection 
(approximately 30 minutes of behavioural testing per day), relative to DLMO. 
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Figure A-2. Compiled baseline data for Subject 2. The graph represents the subject’s baseline melatonin 
profile, generated from three days of saliva samples. Due to circumstances beyond our control, this 
participant missed several collection time points. The red circles represent the times at which samples 
were taken relative to DLMO (time 0), as well as the resulting concentration of melatonin in pg/ml 
(determined using an ELISA). The blue line represents a sinusoidal fit to the data points. The black bar at 
the bottom represents the subject’s average sleep time relative to DLMO. The blue bars represent the 
average range of times of breakfast, lunch and dinner relative to DLMO. The red arrow indicates the time 
at which the subject performed the emotional Stroop task on days 2 and 3 of saliva collection 
(approximately 30 minutes of behavioural testing per day), relative to DLMO. 
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Appendix H – Cost Breakdown!
 
ELISA Kits: 
Price per kit: $649.75 
Number of samples collected: 2,480 
Kits needed to analyze all samples collected: 57 
Kits needed to analyze all samples from experimental period: 44 
Total price of 57 kits: $37,035.75 
Total price of 44 kits: $28,589 
*5 kits already purchased for $3,248.75 by Dr. Joseph DeSouza’s FoH and Start Up Grants 
 
 
Microtubes for Saliva Collection: 
Prices paid per package (1 package = 500 tubes): $47.54 x 1, $43.00 x 3, $39.54 x 1 
Number of packages ordered: 5 
Total cost of microtubes: $216.08 
*Cost of microtubes already paid for in full by Dr. Joseph DeSouza’s FoH and Start Up Grants 
 
 
MRI Scanning: 
Price per hour of scanning: $350 
Total participants scanned: 10 participants scanned 2 times each for 0.5 hours per scan 
Average hours of scanning used: 10 hours 
Total cost of scanning: $3,500 
*Cost of MRI scanning already paid for in full by Dr. Joseph DeSouza’s FoH and Start Up 
Grants 
 
 
Total cost needed to complete all aspects of project: $40,751.83 !!
